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Summary 
Analyses of genome-wide association study data have demonstrated that there are 
potentially thousands of loci associated with schizophrenia (Sullivan et al. 2003). Although 
risk is partially explained by the additive effects of top-ranking polymorphisms, genetic 
interactions may help to explain additional heritability (Hemani et al. 2014; Zuk et al. 2012). 
However, attempts to identify disease-associated pair-wise interactions through 
exhaustive testing have so far been unsuccessful due to the large burden of multiple testing 
and the absence of easily discoverable interactions of large effect (Moskvina et al. 2011). 
Here we investigate whether evidence for a contribution to disease risk from SNP-SNP 
interactions can be found by searching for sets of genes enriched for nominally associated 
interactions. 
When performing interaction analyses covariates were introduced to account for 
population structure. Where the effect of covariates needs to be accounted for, the most 
widely used method modifies the basic logistic regression interaction analysis by simply 
adding covariate terms into the model. The performance of this method was compared to 
two alternative approaches: adding covariate-SNP interactions terms in addition to the 
individual covariate terms, as suggested by (Yzerbyt et al. 2004); and testing for 
interactions in each population separately, then using meta-analysis to combine 
interaction effects. Results and running time were similar whether SNP-covariate terms 
were included or not, while the meta-analytic approach was found to be the most efficient 
in terms of running time. 
To try and identify sets of genes enriched for nominally associated interactions, two 
approaches were investigated: one based on genetic information alone, and one based on 
functional information using protein-protein interactions (PPI). The first approach analyzed 
the distribution of interaction p-values after ranking them by the gene-wide main effects 
of the contributing genes, allowing a comparison to be made between genes with high/low 
gene-wide association. The second approach asked whether genes encoding directly 
interacting proteins were enriched for nominally associated interactions, drawing upon 
two PPI datasets: one from a large experimental (yeast two-hybrid) screen, the other 
consisting of PPI data curated from the literature. In both of the genetic datasets studied 
there was evidence for enrichment of nominally associated interactions amongst genes 
with highest gene-wide association for schizophrenia. There was no evidence for an excess 
of nominally associated interactions when investigating either PPI dataset.  
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Chapter 1 -  Introduction 
1.1  Schizophrenia 
1.1.1  History 
The concept of schizophrenia has recent origins despite the fact that some of the specific 
aspects of the disorder appeared to have been known from the Middle Ages (Jeste et al. 
1985). Dr Emil Kraepelin was the first to identify the disease in 1887 under the name of 
“dementia praecox”.  It was the first time that schizophrenia was separated from other 
forms of psychosis. Kraepelin thought that his dementia praecox was a brain disease 
differentiated from dementia by the fact that it occurred early in life. 
Eugen Bleuler introduced the term schizophrenia in 1911. The word schizophrenia comes 
from the Greeks schizo and phrene. Schizo can be translated as split and phrene as mind. 
Bleuler noted that schizophrenia was very complex in the sense that it seemed to appear 
as a group of diseases, due to the wide variety of symptoms observed between individuals. 
He was also the first person to separate the symptoms in two categories: positive 
symptoms and negative symptoms. 
1.1.2  Disease 
Schizophrenia is a severe psychiatric disorder, estimated to affect approximately 1% of the 
population (Owen et al. 2005). The onset of the disease lies in adolescence or early 
adulthood and often results in a lifetime of illness and treatment. Consequently, 
schizophrenia has a strong impact on the patient’s life, their family and on the public health 
service. 
1.1.2.1  Symptoms 
To diagnose schizophrenia, patients have to fulfil certain criteria. The Diagnostic and 
Statistical Manual of Mental Disorders (DSM-5) provides a list of symptoms and behaviours 
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that enable psychiatrists to identify the disease. As schizophrenia‘s phenotype is very 
complex and heterogeneous, patients show diverse symptoms. Moreover, schizophrenia 
is a long-term mental health disorder and symptoms can also evolve. The main symptoms 
of the disorder can be classified in four categories: positive, negative and cognitive 
symptoms and disorganization of thinking and behaviour. 
Positive symptoms appear to imitate at the excess or distort normal behaviours. Such 
symptoms can appear and disappear. They can also depend on the treatments that the 
patient is taking. Patients generally live in a distorted reality. The degree to which a patient 
is affected can also vary: one person could show a severe form of the symptoms whereas 
in another patient it would be hardly noticeable. Hallucination is when a person sees, 
smells, hears or feels things that do not exist. The most well-known symptom amongst 
individuals suffering from schizophrenia is the hearing of voices. Other hallucinations 
include seeing people or sensations of being touched when no one is physically present. 
Delusion is a false belief based on a mistaken or unrealistic view and is not part of the 
person’s culture. Despite being shown that it is illogical or untrue, patients experiencing 
both hallucinations and delusions will still hold strongly to their beliefs, as they feel very 
real. 
Negative symptoms include signs that disrupt emotions or behaviours including but not 
limited to lack of emotions, affective blunting, poverty of speech, or a loss of interest in 
everyday activities. It is sometimes hard to recognise whether such indications are part of 
the development of the disease or characteristics caused by something else. These 
symptoms are the least likely to improve in the patients. 
Cognitive symptoms include cognitive deficits such as poor ability to make decisions, 
problems with memory, the inability to focus or a lack of understanding information. 
Although cognitive deficiencies are frequently observable, it has to be noted that such 
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observations vary dramatically across individuals. Moreover, cognitive impairment has only 
been recently recognised as a fundamental symptom of schizophrenia. 
Disorganized thinking is an unusual way of thinking. This happens when the patient cannot 
connect their thoughts in a logical way or by poverty of thought content (Tandon et al. 
2009). This can also be expressed though a patient’s difficulty in holding a conversation. 
1.1.2.2  Treatment 
Schizophrenia is a complex disorder and the cause of the disease is not yet known to its full 
extent (Tandon et al. 2008). So far, available treatments have been focused on helping 
patients to deal with their symptoms or to eliminate them. For example Clozaril, a form of 
Clozapine is an antipsychotic medication.  
1.1.3  Epidemiology 
To characterise the epidemiology of a disease, two indicators are usually used: incidence 
and prevalence. The incidence is the number of observed new cases developed over a 
period of time in a population at risk with the disease. The prevalence is the number of 
new and previously existing cases who have the disease at a particular time within a 
defined population. 
Numerous epidemiological studies have been done on schizophrenia. An analysis of the 
prevalence from 188 studies that covered 46 countries calculated the median prevalence 
estimate at 4.6 per 1,000 (Saha et al. 2005). Regarding the incidence rate, research showed 
that results range between 0.16 and 0.42 per 1,000 (Jablensky 2000). While differences 
have been observed between economically rich and more economically impoverished 
countries, these differences essentially concern the progression and consequence of the 
disease (Jablensky 2000): there is no evidence that the economic status of a country 
influences the incidence rates of schizophrenia (Saha et al. 2006). A meta-analysis of all 
published studies between 1965 and 2001 showed that variation in the incidence of 
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schizophrenia was highly associated with sex, urbanity and migration (McGrath et al. 2004). 
Another review also noted that the clinical features of the disorder vary significantly from 
one patient to another (Rössler et al. 2005). 
1.1.4  Genetics of schizophrenia 
1.1.4.1  Heritability 
Heritability is the proportion of variance in a particular trait, in a particular population, at 
a particular time that is due to genetic factors. 
A given phenotype (P) for a particular trait at a particular time in a particular population 
can be modelled as the sum of the unobserved genotype (G) and the unobserved 
environment (E) as follow: 
𝑃ℎ𝑒𝑛𝑜𝑡𝑦𝑝𝑒 (𝑃)  =  𝐺𝑒𝑛𝑜𝑡𝑦𝑝𝑒 (𝐺)  +  𝐸𝑛𝑣𝑖𝑟𝑜𝑛𝑚𝑒𝑛𝑡 (𝐸)  
Consequently the variance of the observable phenotype can then be defined: 
𝜎𝑃
2 = 𝜎𝐺
2 + 𝜎𝐸
2 
Where 𝜎𝑃
2is the phenotypic variance, 𝜎𝐺
2 is the genetic variance and 𝜎𝐸
2 the environmental 
variance. 
The broad sense heritability H2 is defined as the proportion of the observed trait variances 
that is due to all genetic factors: 
𝐻𝑒𝑟𝑖𝑡𝑎𝑏𝑖𝑙𝑖𝑡𝑦(𝑏𝑟𝑜𝑎𝑑 𝑠𝑒𝑛𝑠𝑒) = 𝐻2 =
𝜎𝐺
2
𝜎𝑃
2 
The genetic variance can then be defined as the following: 
𝜎𝐺
2 = 𝜎𝐴
2 + 𝜎𝐷
2 + 𝜎𝐼
2 
Where 𝜎𝐴
2is the variance of additive effects, 𝜎𝐷
2 is the variance of dominant effects and 𝜎𝐼
2 
the variance of interaction effects. 
 
The narrow-sense of heritability h2 is defined as the proportion of the observed trait 
variances that is due to additive genetic factors only: 
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𝐻𝑒𝑟𝑖𝑡𝑎𝑏𝑖𝑙𝑖𝑡𝑦(𝑛𝑎𝑟𝑟𝑜𝑤 𝑠𝑒𝑛𝑠𝑒) = ℎ2 =
𝜎𝐴
2
𝜎𝑃
2 
Where 𝜎𝐴
2is the variance of additive effects, 𝜎𝑃
2 is the phenotypic variance. 
Schizophrenia is a highly heritable disorder in which genetic factors account for 80% of the 
variability in liability (Sullivan et al. 2003). Estimates of heritability from twin studies 
(Cardno and Gottesman 2000) varies from 80-85%. 
1.1.4.2  Genome Wide Association Studies 
Association studies such as Genome Wide Association Studies (GWAS) take the following 
approach: the location of the causal variants is not assumed to allow an unbiased search 
using association principles (Hirschhorn and Daly 2005).  Moreover, such a method is more 
suited to identify variants of smaller effect than those detected by early linkage studies 
(Risch and Merikangas 1996). 
GWAS assume that common variations contribute to the heritability of common diseases 
(Reich and Lander 2001). This method focuses on comparing allele frequencies between 
individuals affected by schizophrenia (cases) and healthy individuals (controls). If an allele 
has a higher frequency in cases than in controls, then this allele will be considered to be 
associated with the disease. Using such a method has only been possible because of the 
characterisation of linkage disequilibrium (LD) between SNPs via the HapMap project 
(International HapMap Consortium 2003). LD exists when genotypes at different loci are 
not independent of another: there is a non-random association. By sequencing millions of 
variants, the HapMap project (International HapMap Consortium 2003) examined LD 
patterns between SNPs and concluded that because neighbouring SNPs are very likely to 
be correlated, only a subset of variants need to be selected in order to look for association 
across the genome (Hirschhorn and Daly 2005). Consequently, if a SNP has been found to 
be associated with the disease, either this marker is causal (directly associated) or it is in 
LD with the causal variant (Bergen and Petryshen 2012), which is more likely. Statistical 
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analysis is carried out to investigate the likelihood of each variant to be associated with the 
disease (or trait). The power of GWAS depends on the effect size, the frequency of the 
SNPs and the sample size (Klein 2007). 
Using a case-control population, hundreds of thousands of variants are genotyped across 
the genome using commercial SNPs arrays. Imputation methods are used in order to 
increase the number of SNPs: the genotype of one variant can be used to predict the 
genotype of the neighbouring markers as neighbouring SNPs are almost always at least 
partially correlated with each other (Hirschhorn and Daly 2005). 
In order to evaluate interesting results and to limit false positive results, a threshold for 
genome-wide significance is used. Conservative approaches such as Bonferroni determine 
the threshold by using the number of tests performed. However it has been showed that 
the number of tests should not be the only determining factor but rather best practice 
should estimate the probability to obtain a true association at any loci. Indeed the strength 
of evidence in a GWAS depends on the likely number of true associations and on the power 
to detect true interactions. But the latter depends on effect sizes and sample size. As a 
result a threshold of 5e−8 has become the significance standard in GWAS (International 
HapMap Consortium 2005). 
One of the first GWAS of schizophrenia was published in 2006 (Mah et al. 2006) showing 
only suggestive association. Other GWAS results for schizophrenia then came from the 
results of three studies (Stefansson et al. 2009; Shi et al. 2009; International Schizophrenia 
Consortium 2008) using the following samples: the International Schizophrenia 
Consortium sample (3,322 cases and 3,587 controls), the Molecular Genetics of 
Schizophrenia (MGS) sample (3,967 cases, 3,626 controls), the SGENE sample (2,663 cases 
and 13,498 controls). Those three studies were combined and produced an important 
genome-wide significant result for schizophrenia: an association signal was found within 
the major histocompatibility complex (MHC) region. In addition, the SNP for the gene 
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ZNF804A (Williams et al. 2011) reached genome-wide significance. These studies showed 
that schizophrenia was a highly polygenic disorder, even more than expected (Kavanagh et 
al. 2015). 
Further efforts have been made and sample size has been increased thanks to international 
collaborations. The Psychiatric Genomics Consortium has successfully coordinated the 
largest collaboration for schizophrenia. The latest GWAS results showed 108 loci 
associated with schizophrenia, 83 of which have not been observed before (Schizophrenia 
Working Group of the Psychiatric Genomics Consortium 2014). This could lead to the 
identification of new mechanisms involved in schizophrenia (Doherty et al. 2012). 
However, as with every method, GWAS have limitations and including data from different 
samples comes with challenges. The lack of well-defined cases and controls, heterogeneity 
across samples or population stratification are commonly cited as limitations of the 
method (McCarthy et al. 2008). In addition to a very high number of SNPs being processed, 
there is a pressing need for a strict control of multiple testing in order to limit the discovery 
of false positive results. 
To overcome that difficulty, other methods have been used such as gene-based 
approaches. These methods consider a group of SNPs instead of a single marker. It is then 
possible to include all the variations from each SNP within a gene and to obtain more 
functional information. One commonly used method is based on the smallest SNP p-value 
within a gene and on the number of SNPs within the same gene. Moreover, as the number 
of genes is significantly smaller than the number of markers, it eases the multiple testing 
problem (Hirschhorn and Daly 2005). However the presence of LD between SNPs implies 
that tests are not independent rending the correction applied by some methods 
insufficient.  
Other approaches have been based on the Brown method (Brown 1975) to combine non-
independent p-values. This method is derived from Fisher’s combined probability test 
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(Littell and Folks 1971) and uses a theoretical approximation of Fisher’s statistics  
(Moskvina et al 2011).  
The approximation Fisher’s statistic combines probabilities and has a chi-square 
distribution (2N degrees of freedom, N being the number of variants) as described below: 
−2 ∑ log (
𝑘
𝑖=1
𝑝𝑖) ~𝜒2𝑘
2  
with 𝑝𝑖  representing the gene wide p-values for the gene 𝑖 and 𝑘 is the number of values 
being combined (here k = 2).  
It calculates the significance of a set of variants in a gene by combining p-values from SNPs 
and by taking into account the number of variants and the LD between them. The resulting 
gene-wide significance p-value reflects the degree of association of a gene with the 
disease. 
Moreover, when looking for rare variants through linkage disequilibrium with common 
SNPs, detecting such variants with a GWAS can be very challenging. In conclusion, GWAS 
approaches have allowed for the discovery of new loci associated with susceptibility for 
schizophrenia. But this approach is also complementary with the previously known method 
such as linkage studies. 
1.1.4.3  CNV studies 
Copy Number Variations (CNVs) are structural variants. A CNV is a portion of DNA larger 
than 1000 bp that is either duplicated or deleted. As a result one individual could have a 
different number of copy of any genes. Algorithms have been developed over the years in 
order to detect such variations and to allow genome-wide calling using data from GWAS 
genotyping (McCarroll et al. 2006). 
Several studies have showed that individuals affected by schizophrenia tend to have an 
increased number of CNVs (Walsh et al. 2008; International Schizophrenia Consortium 
2008; Kirov et al. 2009). It seems that the effect size of CNVs is larger than those detected 
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by GWAS. Moreover it has also been reported that CNVs associated with schizophrenia are 
involved in other disorders including autism and ADHD (Sebat et al. 2007; Williams et al. 
2010). 
1.1.4.4  Rare variants 
Rare variants correspond to alleles having a population frequency under 1%. 
In order to detect rare risk variants that contribute to the heritability, variants need to have 
a relatively large effect size. However there might be rare variants of small effect that 
contribute to disease but that are extremely hard to detect even when using a large sample 
size. 
Rare variants with large enough effects cannot be detected by common methods such as 
GWAS, Next Generation Sequencing (NGS) methods need to be used, for example exome 
sequencing or whole genome sequencing. Whole genome sequencing involves obtaining 
the sequences of the entire genome of an individual, whereas exome sequencing targets 
the protein coding genes in an individual’s DNA. Exome sequencing is often preferred to 
whole genome sequencing as its cost is reduced hence preventing the limitation of small 
studies. 
Recently two studies (Purcell et al. 2014; Fromer et al. 2014) took a closer look at rare 
variants that could potentially contribute to schizophrenia. The first study (Purcell et al. 
2014) compared the exome sequences from 1,500 cases and 2,500 controls of a Swedish 
population. 
The second study (Fromer et al. 2014) looked for de novo mutations within protein-coding 
genes by analysing 600 trios (affected probands with healthy parents). De novo mutations 
are mutations that are present in the offspring but that does not exist in both parents. 
Both studies confirmed the polygenic nature of schizophrenia and that the disease tends 
to involve functionally related genes: genes related to neuronal function or synaptic 
signalling. 
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1.2  Interaction and epistasis 
1.2.1  Gene-gene interactions 
1.2.1.1  History 
The idea of gene-gene interaction was first introduced by William Bateson in 1909 in his 
book Mendel’s Principle of Heredity. By looking at flower colour in peas and combs in 
chicken, he observed that the transmission rates of some variants deviated from the 
Mendelian ratios. In his report he suggested that a pair of gene alleles could affect the 
alleles from another gene. Translating to genetics, one variant could prevent another one 
from expressing its effect. This can be viewed as an extension of the concept of dominant 
and recessive genes: one gene has an ascendant effect over another one. As a 
consequence, in the presence of a variant, a phenotypic change could be observed or could 
modify a mechanism of gene expression. 
In 1918, Fisher gave another definition of epistasis. He argued that alleles from different 
genes could have an additive effect on the considered phenotype and that any deviation 
from this effect should be considered as epistasis. This definition made it possible to define 
a mathematical model that describes the relationship between a phenotype and a 
genotype under or not the influence of an interaction. 
 
1.2.1.2  Definition 
Epistasis could simply be defined as an interaction between genes that affect a phenotype. 
However distinction is often made between three type of epistasis (Moore and Williams 
2005): compositional epistasis, functional epistasis and statistical epistasis.  
Compositional epistasis is comparable to Bateson’s original definition. It refers to the 
masking effect of one locus to another locus (Moore and Williams 2005).  
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Functional epistasis corresponds to physical interactions among proteins or other 
molecules with an impact on the phenotype. This type of epistasis cannot be inferred from 
genetic data, it needs biological experimental validation.  
Statistical epistasis is closer to Fisher’s definition of epistasis. It refers to a phenotypic 
deviation from an additive effect due to combinations of loci.  
The latter definition allows the use of mathematical modelling to detect epistasis in disease 
traits and will be the one used in this thesis. The working hypothesis is that if two SNPs 
interact to increase the disease risk, then the combination of alleles associated with 
increased risk will occur more frequently within the case population than within the control 
population.  
1.2.1.3  Heritability and gene-gene interactions 
While it has been established that there are potentially hundreds of loci associated with 
schizophrenia (Schizophrenia Working Group of the Psychiatric Genomics Consortium 
2014) these findings do not fully explain the risk of disease: only a proportion of the 
heritability is explained (Lee et al. 2012). In the case of schizophrenia, the latest estimates 
suggests that one half to a third of the genetic contribution of risk is captured by the 
variants detected by GWAS (Schizophrenia Working Group of the Psychiatric Genomics 
Consortium 2014). This ‘missing’ heritability could also be attributed to gene-gene or gene-
environment interactions (Zuk et al. 2012). Indeed, other non-additive effects are likely to 
contribute to disease heritability although the size of their contribution is difficult to 
estimate (Zuk et al. 2012). 
1.2.1.4  Evidence for gene-gene interactions 
From a biological standpoint, there is no a priori reason to expect that traits should only be 
additive (Zuk et al. 2012). Evidence for genetic interactions has been reported in many 
model organisms; for example detection of two-loci interactions in a yeast cross (Bloom et 
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al. 2013), positive epistasis involving essential genes in Escherichia coli and Saccharomyces 
cerevisiae (He et al. 2010). 
Many methods have been developed to identify genetic interactions in human GWAS data 
(Wei et al. 2014) and will be discussed in the next section.  
Even though most of the studies only looked at pair-wise interactions between two SNPs, 
there is a possibility that high-order interactions also play a role. However these are harder 
to detect: the number of interactions to calculate is extremely high and as a result very 
large sample sizes are needed (Cordell 2009). 
1.2.1.4.1  In complex disorder 
Several large-scale interaction studies have now evaluated evidence for interactions across 
the genome for several complex disorders (Wei et al. 2012). Among those studies, different 
methodologies have been used to evaluate gene-gene interactions. For example a 
genome-wide interaction-based association using data from the Wellcome Trust Case–
Control Consortium identified interaction for Crohn's disease and coronary artery disease 
(Liu et al. 2011). Still using the WTCCC data, two genome-wide searches for pairwise 
interactions in each of the seven traits studied reported significant interactions (Lippert et 
al. 2013; Wan et al. 2010) however many detected effects were in the MHC region and 
replication was not attempted.  
Significant interactions between SNPs have also been reported for Bipolar Disorder 
(Prabhu and Pe’er 2012). 
Multiple sclerosis is another complex trait in which epistasis has been demonstrated to 
have an impact (Lincoln et al. 2009; Gregersen et al. 2006). Analysis in human populations 
showed an association between a form of multiple sclerosis and interacting loci (Gregersen 
et al. 2006). 
Unfortunately out of these potential interactions, only a few have a functional basis 
(Phillips 2008). 
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1.2.1.4.2  In schizophrenia 
Genome-wide interaction studies have been quite unexplored in schizophrenia. A few 
studies have provided evidence supporting a role for gene-gene interactions in the disease. 
Epistatic interaction between DISC1, CIT and NDEL1 have been reported to impact risk for 
schizophrenia and was validated by functional neuroimaging (Nicodemus et al. 2010). The 
same group also reported significant interactions between the genes NRG1, ERBB4, and 
AKT1 (Nicodemus et al. 2010). Other studies have also shown evidence that genes interact 
in schizophrenia the two genes DISC1 and PDE4B have been found to interact (Millar et al. 
2005). 
1.2.2  Methods to detect gene-gene interactions 
Different methods have been explored in order to detect epistasis (Cordell 2009). These 
methods can be classified into broad groups, described in more detail below: regression 
based methods, LD-haplotype based methods, Bayesian methods, Data filtering methods, 
artificial intelligence based methods. 
1.2.2.1  Regression-based methods 
Regression-based methods are the most frequently used approach to calculate statistical 
gene-gene interactions. Such models test whether the relationship between one or several 
predictor variables and an outcome (phenotype) variable is captured by a linear or logistic 
model (Cordell 2009). In order to perform such an analysis it is necessary to test for 
interactions by comparing two models: one containing the interaction term and one 
without. 
Considering a case-control study this can be translated into a mathematical model. 
Let 𝑋1 and 𝑋2 be two independent variables with three levels (0/1/2) corresponding to the 
genotypes of the considered markers (aa/Aa/AA). 
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Let 𝑌 be the dependent variable that represents the disease status of each individual. In a 
case-control analysis, this outcome variable would be the log odds of the phenotype: the 
disease status of an individual (i.e. case or control). This variable is a function of the 
previous variables 𝑋1 , 𝑋2 and 𝑋1 × 𝑋2, the latter represents the interaction. 
Let 𝛽𝑖 the standardized beta coefficients: 𝛽0 is the Y-intercept. 
Let 𝜀 be the random error component. 
Translating this into a mathematical formula would correspond to the following equation: 
𝑌 ~ 𝛽0 + 𝛽1𝑋1 + 𝛽2𝑋2 + 𝛽3(𝑋1 × 𝑋2) +  𝜀       
 (1) 
Testing for interaction between the two markers corresponds to a comparison of the above 
model (which contains both the main effect and the interaction terms) with another model 
where only the main effects are present, testing whether the regression coefficients 
associated with the interaction term in the above equation equal zero or not. This 
corresponds to a one-degree freedom test of 𝛽3 = 0. 
While it is possible to use GWAS data to perform a genome-wide study of epistasis (Wei et 
al. 2014), this approach suffers from several limitations. The sample size required to detect 
interaction signals needs very large. Indeed it scales inversely with the square of the effect 
size (Zuk et al. 2012): for n loci, the sample size to detect the n2 interactions scales with n4. 
As a result the power to detect interactions in current studies is low (Zuk et al. 2012). 
Additionally, genome-wide interaction studies suffer from the high burden of multiple test 
correction. To account for all pair-wise interactions between 𝑁 markers, 
𝑁∗(𝑁−1)
2
 
interactions must be calculated. For example using 5,000 markers will result in 12,497,500 
interactions calculated. If the Bonferroni multiple testing correction were to be used, the 
level of detection for a single test p-value would be 4e-9. 
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1.2.2.2  LD and haplotype based methods 
LD based methods compare LD between SNPs within cases and controls in order to detect 
interactions. Studies have been performed and seem to detect interactions within genes 
using LD rather than within SNPs (He et al. 2011). 
Haplotype based methods infer haplotypes from genotypes issued from GWAS and use 
estimates of linkage between SNPs (Zhang et al. 2012). However simulation studies have 
shown a greater risk of type I error when the two SNPs are highly correlated or have 
significant main effects (Ueki and Cordell 2012). 
1.2.2.3  Bayesian methods 
Bayesian methods are based upon Thomas Bayes theorem, which calculate conditional 
probabilities based on prior distributions of parameters in a model as well as in the 
observed data (Wei et al. 2014). Such methods offer a different approach for selecting key 
predictor variables (and interactions between them) in order to best predict the phenotype 
(Cordell 2009). Because of the specification of prior distributions of the parameters, this 
approach differs from frequentist-based statistics (Cordell 2009). 
For example, the Bayesian epistasis association-mapping (BEAM) algorithm identified 
epistasis associations in case-control studies using a Markov chain Monte Carlo method, 
incorporating prior knowledge about each marker in order to identify interactions (Zhang 
and Liu 2007). 
In addition several studies have tried to combine a Bayesian framework with generalized 
linear models in order to detect epistasis (Yi et al. 2011). This approach can be 
advantageous as it can take into account covariates or gene-environment interactions. 
1.2.2.4  Data filtering methods 
Data filtering methods make use of biological knowledge (Turner et al. 2011) such as 
disease pathways, protein-protein interactions or features such as the frequency of a 
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variant (Ackermann and Beyer 2012) in order to select a subset of SNPs prior to pair-wise 
interaction analysis. By identifying groups of markers between which interactions are more 
likely to appear, interactions may be easier to detect due to the reduced multiple testing 
burden. However prior selection of the SNPs could lead to miss detection of certain 
interactions as SNPs that interact together might not have been all selected (Wei et al. 
2014). 
Data-filtering methods considerably improve the interpretability of results especially when 
the analysis is driven by a biological hypothesis. However such methods can be a source of 
bias due to their initial hypothesis (Wei et al. 2014): analysis implies less tests to perform 
and less severe correction. 
1.2.2.5  Machine Learning 
In recent years, machine learning methods and data-mining algorithms have been used to 
search for epistasis (Wei et al. 2014). Despite limited success so far, these methods could 
be a potential asset in the search for higher order interactions. Regression models are 
limited in such analyses due to the curse of dimensionality: if the number of predictors 
increases, so does the number of interactions in an exponential way. Due to this 
combinatorial complexity, regression methods are limited in the number of predictors used 
in their analysis and machine learning based methods could be useful to deal with this issue 
(Hu et al. 2013). However, despite the fact that computational efficiency improves, even 
machine-learning methods struggle to analyse higher order interactions (Cordell 2009). 
1.2.3  Challenges to detect epistasis 
When performing genetic interaction analysis, many challenges arise and power to detect 
interactions can be influenced by many factors described below (Wei et al. 2014). 
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1.2.3.1  Linkage disequilibrium 
While the most highly associated variants detected by GWAS may be true causal variants, 
they are more likely to be in LD with the true causal variants. In the latter case a problem 
arises as the variance explained by such SNPs would be less than the variance explained by 
the causal markers (Wei et al. 2014). Indeed, the additive effect of the observed marker is 
correlated with the LD between that marker and the causal variants, thus if there is low LD 
between the causal and the observed SNPs then the additive effect will be little and any 
epistatic effect will be very hard to detect. To counteract this, denser genotype or high 
quality imputation can be use and could help to detect epistasis. 
1.2.3.2  Curse of dimensionality 
When performing a gene-gene interactions analysis, all pair-wise interactions between all 
the SNPs are calculated, assuming the analysis is reduced to a search for binary 
interactions. In that case, the number of possible combinations increases exponentially. If 
N markers are considered, then the number of calculated interactions is   
𝑁∗(𝑁−1)
2
. If higher-
order interactions are calculated, this number rises even more. With so many results, there 
is a risk that any true signal will be obscured by the noise produced by such analysis: this is 
the curse of dimensionality (Wei et al. 2014). 
Moreover the significance level required to survive multiple testing correction is much 
more stringent for interactions than main effect association. This reinforces the need to 
increase the sample size in order to detect any epistatic effect (Wei et al. 2014). 
1.2.3.3  Replication 
In order to confirm putative genetic interactions, results need to be replicated. However 
this has proven to be difficult for epistasis analysis (Combarros et al. 2009): replication 
rates for gene-gene interactions are expected to be lower than those for additive effect 
studies (Wei et al. 2014). Indeed, finding the same direction of effect for one interaction 
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within two independent populations will be extremely hard due to LD differences between 
the populations. When looking at variants in high LD within a sample, the same variants 
might not have the same LD within a population resulting in bias within the discovery 
sample (Cordell 2009). The use of very dense and similar data could help to overcome this 
problem. 
1.2.4  Choice of methodology 
In this thesis, two methods were combined to calculate SNP-SNP interactions: filtering on 
LD and logistic regression model. By filtering on LD, the number of variants used in the 
interaction analysis is significantly reduced. It allows avoiding collinearity problems and to 
limit the number of interactions to calculate as well as the multiple tests burden. As 
interaction analysis is time consuming and computationally intensive reducing the number 
of variants is vital for feasibility. However by applying such filter information can be lost 
(SNPs that interact together might bot be selected) but the variants analysed are semi-
independent. 
In addition the logistic regression model is the most natural and used model to calculate 
interactions (Cordell 2009). Many tools such as Plink (Purcell et al. 2007; Chang et al. 2015) 
are available to use this method. 
1.3  Protein-protein interactions 
1.3.1  Introduction 
Protein-protein interactions (PPIs) have a key role in many processes in a cell. Activities of 
PPI complexes range from protein folding to transport, degradation, transcription, 
transduction or cell signalling for example.  This makes PPI complexes one of the most 
important components in a cell. 
The human genome contains approximately 19,000 protein-coding genes suggesting that 
the possible number of interactions is very large and that the number of discovered 
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interactions is probably very low (Rual et al. 2005). Several powerful methodologies and 
techniques have been developed to discover protein–protein interactions data such as 
Yeast two-hybrid (Ito et al. 2001), co-purification or fluorescence energy transfer. 
Finding PPIs has been an important challenge in the last decade to identify all the complex 
mechanisms used at a cellular level. With a better knowledge of PPIs it is possible to 
understand a protein’s function and behaviour or to characterise proteins complexes and 
pathways (Koh et al. 2012). 
1.3.2  Databases 
1.3.2.1  Primary and secondary databases 
Primary databases include interactions that are experimentally determined. Those 
databases generally contain information on the data model and the data extraction 
method that has been used. New records are added after manual curation of interactions 
from the literature. In some cases, users are allowed to submit their own interactions 
pending verification. Most of those databases contain added information such as 
functional annotations, sequence information, gene references. 
Some example of this resources includes but is not limited to the Biomolecular Interaction 
Network Database (BIND) (Bader et al. 2003), the Biological General Repository for 
Interaction Datasets (BioGRID) (Stark et al. 2011), the Database of Interaction Proteins 
(DIP) (Salwinski et al. 2004), the Human Protein Reference Database (HPRD) (Mishra et al. 
2006), the protein InterAction database (IntAct)(Kerrien et al. 2007), the Molecular 
INTeraction database (MINT) (Ceol et al. 2010)and the Munich Information Center for 
Protein Sequence (MIPS)(Pagel et al. 2005). Table 1.1 displays the main characteristics of 
primary databases including the number of interactions available in each of them. 
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Often called meta-databases, secondary databases combine interactions from several 
primary databases in one repository. For example the IMEx consortium combines 
interaction data from 10 databases (Orchard et al. 2007). 
 
1.3.2.2  Predictive databases 
Predictive databases contain interactions that have been identified using either algorithms 
to predict potential interactions using existing data (verified interactions) from curated 
databases, or the protein structures to determine potential interactions. 
1.3.2.3  Limitations 
Despite the effective techniques available to experimentally detect protein-protein 
interactions (Klapa et al. 2013), the above-mentioned databases have limitations. Many 
false positives and false negatives rates are founds within the findings (Berggård et al. 
2007). Moreover the content of the databases often overlaps and is redundant (Cusick et 
al. 2009). 
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Acronym Full Name Species # proteins # interactions # proteins (human) # interactions (human) 
BIND Biomolecular Interaction Network Database All 31,972 58 266 NA NA 
BioGRID Biological General Repository for Interaction 
Datasets 
All(H) 18401 147500 18401 147500 
DIP Database of Interacting Proteins All(H) 27098 78191 4283 7140 
HPRD Human Protein Reference Database Human 30047 41327 30047 41327 
IntAct IntAct Molecular Interaction Database All 83417 454515 NA NA 
MINT Molecular Interaction Database All(H) 35528 241458 8751 26830 
MIPS-MPPI MIPS Mammanlian Protein-protein Interaction 
Database 
Mammals NA NA NA NA 
Table 1.1: Main characteristics (acronym, name, species, number of proteins and interactions total, number of proteins and interactions in human data) of 
primary databases 
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Many newly discovered PPI published in small-scale studies are not captured by existing 
interaction databases, resulting in a huge amount of data only available through curating 
the literature using databases such as PubMed (Figure 1.1). Manually extracting such 
information is infeasible on a large scale, especially for data-driven approaches. 
In addition there is a need to further analyse the details of PPIs experimentally identified 
on order to better verify the accuracy of experiments. 
All those arguments explain the pressing need to use text-mining methods. 
 
Figure 1.1: Growth of the PubMed database when searching for “protein-protein 
interactions” 
 
1.3.3  Use of text-mining to extract PPI from the literature 
The number of available literature is growing at an exponential rate as generating 
experimental data has become easier. Specifically for protein-protein interactions the 
growing trend is clearly visible (Figure 1.1). 
Retrieving interactions from the published literature has become an important task. 
However such analysis can be extremely time-consuming due to the huge amount of data 
to process. Automated analysis of text can help researchers to evaluate the available 
literature. 
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Text mining was first defined by Marti Hearst as the following: “Text Mining is the discovery 
by computer of new, previously unknown information, by automatically extracting and 
relating information from different written resources, to reveal otherwise "hidden" 
meanings.” 
Text mining allows the extraction of precise information (PPI for example) based on more 
than just a simple search for keywords. It searches for entities, concepts, relationships, 
phrases, sentences or information in a specified context. In order to achieve that task, it is 
possible to use different techniques such as text processing or machine learning 
techniques. Three main steps are part of the text mining process: information retrieval, 
Name Entity Recognition and information extraction. 
Information retrieval is the first phase of a text-mining process. In order to extract 
information from the literature, the relevant texts need to be retrieved. This step is usually 
performed using keywords to query a database such as PubMed. It is also possible to use 
other source such as patients’ records for example. PubMed is often chosen as it includes 
Medline as a subset and allow the use of Mesh (MEdical Subject Headings) terms. 
The second step of the text-mining process is the Name Entity Recognition (NER). NER is 
the use of search algorithms in order to find occurrence of specific keyword such as protein 
or gene names for example. This complex process is the key to the text mining process. 
NER techniques can allow searching for several keywords associated with unique entity. 
For example, it is possible to search for a gene by its full name or its symbol and it will be 
identified as the same entity. Some text mining tools rely on machine learning techniques 
for NER using Hidden Markov Models (Zhang et al. 2004) or support vector machines 
(Habib and Kalita 2010). These techniques can be combined with rule-based methods 
(Fleuren and Alkema 2015). 
The Information extraction process is purely the detection of the relationship between the 
elements identified by NER. Co-occurrence and natural language processing (NLP) are the 
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most commonly used methods. Co-occurrence methods rely on the idea that if two entities 
are related then they will often appear in the text together (Jensen et al. 2006). Such 
methods can correct for false positives by using a scoring system based on frequency or 
degree of significance (Alako et al. 2005). This method is easy to implement but tends to 
have a lower precision than NLP–based methods. NLP methods are based on the structure 
of a specific language and hence linked to detect information in that language. Additionally 
NLP methods can provide information about the type of the relationship between two 
identities (Ben-Hur and Noble 2005). Compared to co-occurrence method, the precision of 
NLP method is higher but this method can be limited as the detection of relationship 
between entities is only possible by pre-defining the relationships that are searched for. 
Additionally, text mining competitions as the BioCreative challenge (Krallinger et al. 2011) 
have been taking place in the hope of improving the development of text mining tools 
(Fleuren and Alkema 2015). 
1.4  Aims and objective of the thesis 
This thesis is divided in two parts. 
The first aim was the comparison of different methods to identify genetic interactions by 
taking into account population structure. 
The second objective was to try to identify sets of genes enriched for SNP-SNP interactions 
by investigating two different approaches. The first approach was based on genetic 
information alone. The second approach was based on functional information using 
protein-protein interactions. 
1.5  Chapter’s outline 
Chapter 2 details the two GWAS datasets as well as the quality control steps applied to it. 
These datasets will be used in Chapters 3, 4 and 5. 
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Chapter 3 explores different ways to account for population structure. Three different 
models that include covariates into an interaction analysis were used on the same GWAS 
dataset. Strength and limitations of each method were evaluated. 
Chapter 4 assesses interactions within two independent GWAS datasets. By calculating 
SNPs pair-wise interactions in both datasets, the distribution of interaction p-values is 
analysed after ranking them by the gene-wide main effects. 
Chapter 5 investigates whether protein-protein interactions can be used to identify subsets 
of genes between which significant interactions are more likely to be present. Several PPI 
datasets are compared. 
Chapter 6 will conclude the thesis with a general discussion of the findings, their 
implications and limitations. 
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Chapter 2 -  Description of datasets 
2.1  Introduction 
This chapter describes the ISC (International Schizophrenia Consortium 2008) and CLOZUK 
(Hamshere et al. 2013) Genome-Wide Association Studies (GWAS) datasets that are used 
in the thesis and the quality control (QC) tests that were applied to them. It is known that 
the ability of GWAS to recognize true associated genetic variants relies on the overall 
quality of the data (Turner et al. 2011). Moreover bad quality samples can lead to the 
detection of false positive and negative associations in the data (Turner et al. 2011). In 
addition to this QC is an important step for the reliability of case-control studies (Blomgren 
et al. 2006). 
2.2  Quality controls applied: overview 
All of the QC procedures applied to the two datasets are detailed in the section below: the 
chosen order followed best practice and commonly used QC methods for GWAS (Anderson 
et al. 2010; Wellcome Trust Case Control Consortium 2007; Turner et al. 2011). The QC 
steps at the exception of the Principal Component Analysis (PCA) were performed using 
the genetic analysis tool-kit PLINK (Purcell et al. 2007). The PCA was done using the 
Eigenstrat software (Price et al. 2006). 
2.2.1  Call rates 
Call rates were checked at both variant and individual levels for missing or incomplete data 
in order to exclude them from the analysis. In case-control studies, it is essential to check 
for significant differences in individual call rates between sub populations to ensure that 
the combined set will be homogenous (Anderson et al. 2010). Furthermore, markers with 
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below-average call rates indicate low DNA quality and/or concentration and need to be 
excluded from the analysis. 
Two different thresholds for the variants call rates were compared: 1% and 2%. These 
threshold values are standardly used and indicate a good coverage of the SNPs. In addition 
to this, by comparing the different thresholds, it is ensured that there will be a fair balance 
between having the best genotyping quality possible and dropping a minimum number of 
samples and SNPs (S. Turner et al. 2011). After comparison of the results, the chosen 
threshold was applied to each dataset prior to similar investigation of individual call rates.   
2.2.2  Minor Allele Frequency (MAF) 
The MAF threshold applied varies between studies, usually lying between 1% and 5% 
(Anderson et al. 2010). By applying such thresholds and removing rare variants from the 
analysis, the multiple testing and computational burdens are reduced (S. Turner et al. 
2011) . This has little impact on studies given that the power of detection of associations 
for these variants is low (Morris and Zeggini 2010).  
Moreover, variants with very low frequency can potentially generate additive effects 
statistically (Gibson 2012), which could introduce a bias in an interaction analysis if those 
variants were included. 
2.2.3  Heterozygosity 
The distribution of mean heterozygosity for all individuals was inspected in order to identify 
which individuals to remove: samples with unusually high heterozygosity indicate possible 
sample contamination whereas samples with low heterozygosity indicate samples that do 
not belong to the population (Anderson et al. 2010). Similarly, the distribution of the 
inbreeding coefficient was inspected: samples with unusually low inbreeding coefficient 
indicate contamination. In addition, samples with high inbreeding coefficient also need to 
be removed because standard case-control analyses assume individuals are independent. 
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Individuals with outlying heterozygosity rates and outlying inbreeding coefficients were 
identified and removed from the analysis. 
2.2.4  Cryptic relatedness 
Relatedness among samples leads to an over-representation of selected alleles and can 
confound the analysis and the discovery of true associated variants (S. Turner et al. 2011). 
Related individuals were then excluded from the analysis. The identity by descent (IBD) 
threshold used was 0.1875 as it is intermediate between second and third degree relative 
(Anderson et al. 2010). 
2.2.5  Hardy Weinberg 
Markers with significant deviation from the Hardy Weinberg equilibrium need to be 
excluded as this could indicate potential genotype errors (Anderson et al. 2010). The 
threshold was decided at 10-4 for both cases and controls. 
2.2.6  Principal Component Analysis (PCA) 
PCA was used to investigate differences between cases and controls due to ancestry 
dissimilarities. Following the results of the PCA, a clustering algorithm was used to select 
cases and controls that couldn’t be separated in two different groups and to exclude outlier 
individuals. This was done using the library Mclust in R (Fraley and Raftery 2002). 
2.3  ISC Dataset 
2.3.1  Introduction 
This GWA study of schizophrenia, performed by the International Schizophrenia 
Consortium (International Schizophrenia Consortium 2008) is used in Chapter 3 and 4 of 
the thesis. 
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2.3.2  Sample details 
The initial dataset consists of a total of 3,322 individuals with schizophrenia and 3,587 
healthy subjects from 8 different populations (Table 2.1). 
 
Sample Ancestry Cases (N) Controls (N) 
University of Aberdeen Scottish 720 702 
University College London British 523 505 
Portuguese Island Collection Portuguese 347 216 
Karolinksa Institutet Swedish 170 170 
Karolinska Institutet Swedish 390 230 
Cardiff University Bulgarian 528 611 
Trinity College Dublin Irish 275 866 
University of Edinburgh Scottish 369 287 
TOTAL  3,322 3,587 
Table 2.1: Origin of case and control samples for all individuals (N=6909) by samples in 
the initial ISC dataset. 
All of the cases had a diagnosis of schizophrenia based upon DSM-IV, ICD-10 or 
ascertainment through hospital records. The general population of each site was used to 
draw controls often using blood banks. Controls were screened for mental illness in most 
samples. 
2.3.3  Genotyping 
DNA was extracted from whole blood. The genotyping was performed at the Broad 
Institute of Harvard and MIT in Boston, USA. Different chips were used: the Affymetrix 
Genome-Wide Human SNP 5.0 and 6.0 Arrays. To reduce the batch effect, duplicated, 
poorly genotyped and contaminated samples were removed from the dataset. 
More details on the samples and the GWAS are available in the primary manuscript 
(International Schizophrenia Consortium, 2008).  
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2.3.4  Quality controls 
Initially, the dataset contained 6,909 individuals (3,587 controls and 3,322 cases) and 
739,995 SNPs were genotyped. 
2.3.4.1  Call rates 
Call rates for both individuals and variants were investigated separately in each sub-
population: SNP coverage was investigated before the individuals. After comparing the two 
different thresholds (Table 2.2), the threshold for analysis was established at 2%: the best 
balance between the number of variants to exclude and the best genotyping quality 
possible. After removing SNPs with call rates above this threshold in each sub-population, 
all call rates were above 0.96 in every sub-population (Figure 2.1). After exclusions, 
246,455 SNPs remained. No individuals were excluded. 
 
Pop ISC1 ISC2 ISC3 ISC4 ISC5 ISC6 ISC7 ISC8 
1% 75,608 102,262 101,397 66,942 419,822 420,861 378,894 470,808 
2% 42,951 57,612 53,117 35,864 392,891 397,529 366,999 446,025 
Table 2.2: Number of SNPs to be removed in each chip using the different cut-off 
thresholds (1% and 2%) for call rates 
 
2.3.4.2  Heterozygosity 
No specific threshold was applied, as the results were acceptable in the first instance: no 
outlier was identified (Figure 2.2). 
2.3.4.3  Cryptic Relatedness 
No individual was above the chose IBD threshold. 
2.3.4.4  Hardy Weinberg 
251 variants were excluded. 
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Figure 2.1: Ordered individual call rates and Ordered SNP coverage in each population of the ISC dataset after QC.  
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Figure 2.2: Histograms of the mean heterozygosity and of the inbreeding coefficient for the 8 populations of the ISC dataset. No unusual sample is visible as the 
histograms shows a normal distribution in each chip.  
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2.3.4.5  Additional Information 
For every SNP in the dataset, minor allele frequencies were above 1%, suggesting that rare 
variants were previously excluded. 
2.3.5  Summary 
After applying all the various quality control steps mentioned in section 2.2, the final dataset 
contains 3,322 cases with schizophrenia and 3,587 healthy controls. 246,204 SNPs remained 
for the analysis. 
 
2.4  CLOZUK Dataset 
2.4.1  Introduction 
The CLOZUK sample, used in Chapters 4 and 5 of the thesis, was part of a larger GWA study of 
schizophrenia performed by the Psychiatric Genomics Consortium (Schizophrenia Working 
Group of the Psychiatric Genomics Consortium 2014). 
2.4.2  Sample details 
The CLOZUK sample (Hamshere et al. 2013) consists of cases ascertained through facilitation 
with Novartis, the manufacturer of a proprietary form of clozapine (Clozaril). Cases consisted 
of individuals with a clinical diagnosis of treatment-resistant schizophrenia. Controls were 
drawn from Wellcome Trust Case Control Consortium 2 (WTCCC2, Wellcome Trust Case 
Control Consortium 2007). No screening for psychiatric illness was performed. 
2.4.3  Genotyping 
DNA was extracted from blood. The cases samples were genotyped at the Broad Institute of 
Harvard and MIT in Boston, USA. The genotyping, described in (Hamshere et al. 2013), was 
done on two different chips: Illumina HumanOmniExpres-12v1 and OmniExpresssExome-8 that 
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will be denominated as Combo and Omni. The controls from WTCCC2 were genotyped at the 
Wellcome Sanger Institute. 
After imputation, 7,763 individuals and 10,670,661 SNPs were genotyped on the Combo chip 
and 4,233 individuals and 10,663,800 SNPs on the Omni chip. 
2.4.4  Quality controls 
2.4.4.1  Phenotypes 
Individuals with missing phenotypes were excluded from both datasets. Originally the Combo 
chip contained 7,763 individuals including 32 with missing phenotypes. After exclusion, 7,731 
individuals remained, corresponding to 4,285 controls and 3,446 cases. The Omni chip 
contained 4,233 individuals including 111 with missing phenotypes. After exclusion, 4,122 
individuals remained, corresponding to 2,014 controls and 2,108 cases. 
2.4.4.2  Call Rates 
After imputation the Combo chip contained 10,670,661 SNPs and the Omni chip contained 
10,663,800 SNPs. Comparison between allowing 1% or 2% of missingness in SNPs call rates was 
performed (Table 2.3). 
Cut-off threshold Combo Chip Omni Chip 
1% 
6,454,563 SNPs 
(60% of total SNPs) 
5,478,552 SNPs 
(51% of total SNPs) 
2% 
4,772,338 SNPs 
(45% of total SNPs) 
3,969,836 SNPs 
(37% of total SNPs) 
Table 2.3: Number of SNPs to remove in each chip using two different cut-off thresholds (1% 
and 2%) for the SNPs call rates. 
A cut-off threshold of 2% was applied for the SNP coverage in each chip. After applying this 
threshold, all individuals call rates were above 0.98 in both chips indicating high genotype 
reliability (Figure 2.3). 
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Figure 2.3: Call rate and SNP coverage for the Combo chip (Figure A) the Omni chip (Figure B) 
after applying the cut-off threshold of 2% for the SNP coverage. For both chips, the call rate 
and the SNP coverage are above 98% 
After applying the 2% cut-off the numbers of SNPs contained in each chip were as follows: 
5,898,323 variants in the Combo chip and 6,693,964 markers in the Omni chip. 
2.4.4.3  Minor Allele Frequency 
Two different MAF thresholds were used to compare the number of SNPs that could be 
removed: 1% and 5 % (Table 2.4). 
MAF threshold Combo chip Omni chip 
1% 1,030,426 SNPs 1,061,764 SNPs 
5% 2,336,133 SNPs 2,491,123 SNPs 
Table 2.4: Number of SNPs to remove using different MAF threshold in each chip 
 
A threshold of 1% was chosen, as it was a good balance between the number of SNPs to exclude 
and the exclusion of rare variants. After applying the control on minor allele frequency, the 
Combo chip retained 4,867,897 SNPs and the Omni chip 5,632,300 SNPs. 
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2.4.4.4  Heterozygosity 
After checking heterozygosity plots, a few outliers were removed (9 individuals). The final plots 
showed a normal distribution for both the mean heterozygosity and the inbreeding coefficient 
without any outliers (Figure 2.4). 
After removal of outliers, 7,719 individuals were retained on the Combo chip and 4,107 
individuals on the Omni chip. 
 
Figure 2.4: Histograms of the mean heterozygosity and of the inbreeding coefficient for the 
Combo chip (A) and the Omni chip (B). The outliers were previously excluded as those samples 
could have been contaminated or do not belong to the same population. After the removal of 
every unusual sample all the histograms shows a normal distribution in each chip. 
2.4.4.5  Cryptic relatedness 
12 pairs of individuals from the Combo chip were identified as being related, as were 7 pairs of 
individuals from the Omni chip. One individual from each pair was chosen at random and 
removed from the data. 
2.4.4.6  Hardy Weinberg 
All variants passed the Hardy Weinberg thresholds, perhaps indicating that there were 
removed prior to this analysis. 
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Figure 2.5: PC Plots for the CLOZUK dataset (A: Combo chip, B: Omni chip) 
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2.4.4.7  Principal Component Analysis 
Plots of principal components (PC) against each other were drawn and analysed for each 
chip (Figure 2.5). The principal component analysis showed some discrepancies. For the 
Omni chip, cases and controls respectively represented in black and red can be separated 
visually from each other using the first two PCs (Figure 2.5 Right panel B PC1/PC2). For the 
Combo chip, a tail of outliers is clearly visible (Figure 2.5 Left Panel B PC1/PC2), indicating 
non-European ancestry. Following clustering (Section 2.2.6), outliers were then excluded 
from the analysis: 262 in the Combo chip and 472 in the Omni chip. 
 
2.4.5  Summary 
The CLOZUK dataset contains data genotyped using two different chips: Omni and Combo. 
After QC, the Combo chip retained 7,445 individuals: 3,283 cases and 4,276 controls. The 
Omni chip retained 3,628 individuals: 1,917 cases and 1,711 controls. 
Regarding the number of SNPs in each chip, the Combo chip retained 4,867,897 SNPs and 
the Omni chip 5,632,200 SNPs that will be used in the analysis of Chapter 3 and 5. 
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Chapter 3 -  Interaction analysis in GWAS dataset with 
covariates 
3.1  Introduction 
3.1.1  Background 
In complex diseases, gene-gene interaction refers to a phenotype that cannot be explained 
by adding the independent effects of two loci but can modified the prediction by their joint 
effect (Carlborg and Haley 2004). This effect can be modelled by adding an interaction term 
in the analysis. 
The most frequently used model to calculate statistical interaction is based on a 
linear/logistic regression depending on the phenotype distribution. The regression model 
describes the relationship between one outcome variable and one or several predictor 
variables, including the interaction term (Cordell 2009). For a case-control study, the 
interaction model describes the effect of those predictor variables on the log odds of the 
disease. The method consists of testing the interaction term only and was described in 
detail in Chapter 1 based on Cordell (2002). 
The motivations behind the inclusion of covariates into a statistical model are the 
improvement of the precision of the model’s estimates in the presence of potential 
confounders and the maximization of the statistical power (Sham and Purcell 2014). By 
including confounding covariates into an analysis, false positives and false negative 
associations can be reduced, increasing the power of interaction testing (Sham and Purcell 
2014). 
When including covariates into an interaction analysis, the most widely used method 
consists of simply adding the covariate terms into the logistic regression model. However 
it was demonstrated by Yzerbyt et al. (2004) that in specific situations, to be detailed later, 
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this could result in the presence of bias. This paper suggested adding not only the covariate 
terms into the equation but also adding interaction terms between each covariate and 
each predictor variable to control for covariate’s effects. 
3.1.2  Aims of the chapter 
In this chapter three different models for including sub-population covariates into an 
interaction analysis were used on the same GWAS dataset. The first model (widely used) 
consists of adding the covariate terms into the model. The second one follows the 
recommendation by Yzerbyt et al. (2004): it adds into the model the covariates terms as 
above and additional interaction terms between each covariates and each predictor 
variables. In the last model, interactions are calculated independently in each sub-
population and a meta-analysis is used to combine the results. 
The aim of this chapter is to compare the three methods and assess the strengths and 
limitations for each of them. 
3.2  Material and methods 
3.2.1  Data 
For this analysis, the International Schizophrenia Consortium (ISC) dataset was used 
(International Schizophrenia Consortium 2008) as it has a natural population-based 
structure. It consists of a total of 3,322 individuals with schizophrenia and 3,587 healthy 
subjects collected from 8 different populations (Chapter 2, Table 2.1). The data and the 
quality control steps are described in Chapter 2. 
3.2.2  SNPs selection and pruning 
SNPs outside genes were removed and chromosomes X and Y were excluded from the 
analysis as well as insertions and deletions, retaining 95,124 genetic variants. Insertions 
and deletions (indels) were excluded from the analysis due to their rarity as well as the 
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potential inaccuracy of the calling for indels (Hasan et al. 2015). In order to perform SNP-
SNP interactions on X and Y chromosomes, a separate analysis of female and male 
subsamples would have been needed. This would have resulted in analysing samples of 
small sizes resulting in an important loss of power for detection of potential interactions 
as well as an increase number of tests.  
When undertaking a pair-wise interaction analysis there is an interest in reducing the 
number of variants studied (see Chapter 1, section 1.2.3.2). As comprehensive pair-wise 
SNP-SNP interaction analysis is time consuming and computationally intensive when using 
data from genome wide association studies. For this reason, the number of SNPs involved 
in the study needed to be reduced (Moskvina, et al. 2011). 
Linkage disequilibrium (LD) based pruning was used to reduce the number of SNPs by using 
the –clump option in PLINK (Purcell et al. 2007). The following parameters were chosen: a 
window of 2,000 Mb, the significance threshold p1 of 0.01 and r2 of 0.1. LD-based pruning 
also has the advantage of avoiding SNP collinearity. Collinearity happens when a predictor 
variable in a multiple regression model can be estimated from the others variables with a 
high level of accuracy. As the regression model takes into account this uncertainty it does 
not affect the predictive power of the model. However it does increase the standard error 
and affects calculations regarding each predictor. By using LD-based pruning, the 
probability of having linear-dependent variables is decreased.  
Furthermore, as suggested by Price et al. (2008), the major histocompatibility complex 
(MHC) region, known as a high-LD region, was excluded prior to clumping. 
3.2.3  Testing for interactions 
As explained in detail in Chapter 1, statistical interactions are based on a linear/logistic 
regression model and estimate an outcome variable as a function of predictor variables 
(Cordell 2009). Here the analysis is based on a case-control binary phenotype, therefore 
the outcome variable will be the log odds of the disease. 
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Let 𝑋1  and 𝑋2  represent two independent variables with three levels (0/1/2) 
corresponding to the possible genotypes of the markers (aa/Aa/AA). 
𝑌 is the dependent variable that represents the disease status of the individuals: 1 for the 
presence of the disease in the individual (case) and 0 for the absence of the disease in the 
individual (control). 𝑌 is a function of the previous variables 𝑋1 , 𝑋2 and 𝑋1 × 𝑋2, the final 
term representing the interaction. 
Let Ci be the covariate term for covariate variable i. and K be the total number of covariates 
(for the ISC dataset this corresponds to the number of sub-populations). 
Let 𝛽𝑖 be the standardized beta coefficients: 𝛽0 is the Y-intercept. 
Let 𝜀 be the random error component. 
When testing for statistical interactions between two independent variables, the effect size 
of the interaction term between those two variables is tested as shown by the following 
equation: 
𝑌 ~ 𝛽0 + 𝛽1𝑋1 + 𝛽2𝑋2 + 𝛽3(𝑋1 × 𝑋2) +  𝜀      (1) 
In order to assess the significance of the interaction term, the following hypothesis are 
tested: 
𝐻0: 𝛽3 = 0 
𝐻1: 𝛽3 ≠ 0 
using a log-likelihood ratio test and corresponding to the difference in deviances of the fits 
of the two models. 
 
However the effect of covariates needs to be accounted for. It has been shown in previous 
studies that when performing an interaction analysis (Arya et al. 2009), the inclusion of 
covariates into the model can change the overall results.  
The widely accepted method simply adds the covariates into the regression model. 
However it was suggested by Yzerbyt et al. (2004) that just entering the covariates into the 
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model did not control properly for the effect those covariates might have on each marker, 
as it may not only be the main effects that can be influenced by those variables. A 
demonstration of this bias was described in Yzerbyt et al. (2004). Details on specific 
situations, which are outlined as in Yzerbyt et al. (2004), were also shown in Keller (2014) 
and illustrated well the problem for genetic data analysis. One of the main examples cited 
(Kaufman et al. 2004) investigated if a repeat polymorphism (short/long) at the serotonin-
transporter linked region was dependent on childhood maltreatment and social support. 
In that analysis, ethnicity (African-Americans, biracial and non-African Americans) and sex 
were taken into account. The main finding was that the interaction between the 
polymorphic region and childhood maltreatment was significant: the individuals with the 
s/s allele were found to have significantly higher depression scores. It was also found that 
African-Americans have a high frequency of the long repeat than non-African Americans. 
However as the interaction between environment and ethnicity and between the 
polymorphism and ethnicity were not included, it is not possible to completely eliminate 
alternative explanations for the finding. For example the detected interaction could have 
been influenced by ethnicity if due to difference in cultural norms one group does not 
report depression. In a similar way, this example can be translated to SNP-SNP interactions 
and can raise similar issues when integrating covariates into interactions studies. 
3.2.3.1  Method 1: Inclusion of covariates in the regression analysis 
As outlined above, the typically used method includes information about population as 
covariates. It simply involves adding the covariates into the regression model as additional 
terms described in Equation 1. 
𝑌 ~ 𝛽0 + 𝛽1𝑋1 + 𝛽2𝑋2 + 𝛽3(𝑋1 × 𝑋2) + ∑ 𝛽4,𝑖𝐶𝑖
𝑘−1
𝑖=1 + 𝜀     
(2) 
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3.2.3.2  Method 2: Inclusion of covariates and effects between the covariates and the 
markers in the interaction analysis 
This second method controls for all the effects between the covariates and all the markers. 
Like in Method 1 it adds the covariates into the model but it also adds extra interactions 
terms between all the covariates and all the markers as suggested by (Yzerbyt et al. 2004). 
𝑌 ~ 𝛽0 + 𝛽1𝑋1 + 𝛽2𝑋2 + 𝛽3(𝑋1 × 𝑋2) + ∑ 𝛽4,𝑖𝐶𝑖
𝑘−1
𝑖=1
+ ∑ 𝛽5,𝑗(𝐶𝑗 × 𝑋1)
𝑘
𝑗=1
+ ∑ 𝛽6,𝑗(𝐶𝑗 × 𝑋2)
𝑘
𝑗=1
+ 𝜀 
(3) 
 
3.2.3.3  Method 3: Interactions by means of meta-analysis of sub-populations 
 
This last method analyses separately the 8 populations and takes into account the 
directionality of effect size with a meta-analysis as shown below: 
𝑌1 ~ 𝛽1,0 + 𝛽1,1𝑋1 + 𝛽1,2𝑋2 + 𝛽1,3(𝑋1 × 𝑋2) +  𝜀 
 
𝑌2 ~ 𝛽2,0 + 𝛽2,1𝑋1 + 𝛽2,2𝑋2 + 𝛽2,3(𝑋1 × 𝑋2) +  𝜀 
 
𝑌3 ~ 𝛽3,0 + 𝛽3,1𝑋1 + 𝛽3,2𝑋2 + 𝛽3,3(𝑋1 × 𝑋2) +  𝜀 
 
𝑌4 ~ 𝛽4,0 + 𝛽4,1𝑋1 + 𝛽4,2𝑋2 + 𝛽4,3(𝑋1 × 𝑋2) +  𝜀 
𝑌 ~ 𝛽0 + 𝛽1𝑋1 + 𝛽2𝑋2 
+𝛽3(𝑋1 × 𝑋2) +  𝜀 
𝑌5 ~ 𝛽5,0 + 𝛽5,1𝑋1 + 𝛽5,2𝑋2 + 𝛽5,3(𝑋1 × 𝑋2) +  𝜀 
(4) 
𝑌6 ~ 𝛽6,0 + 𝛽6,1𝑋1 + 𝛽6,2𝑋2 + 𝛽6,3(𝑋1 × 𝑋2) +  𝜀 
 
𝑌7 ~ 𝛽7,0 + 𝛽7,1𝑋1 + 𝛽7,2𝑋2 + 𝛽7,3(𝑋1 × 𝑋2) +  𝜀 
 
𝑌8 ~ 𝛽8,0 + 𝛽8,1𝑋1 + 𝛽8,2𝑋2 + 𝛽8,3(𝑋1 × 𝑋2) +  𝜀 
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3.2.3.4  Implementation of the interaction analysis 
The first two methods were run using an R script. The last one used two different software 
packages: Plink 1.9 (Purcell et al. 2007; Chang et al. 2015) and METAL (Willer et al. 2010). 
Plink 1.9, a command line tool designed for large-scale genetic analyses, was used to 
calculate the interactions in each of the 8 samples. METAL, a computationally efficient 
software for genome-wide scans, was used to combine the results. All the analyses were 
run on the Cardiff University High Performance Cluster Raven. 
3.2.4  Notations 
In this chapter, Method 1 will be used to describe the approach adding the covariates as in 
equation 2. Method 2 will describe the approach where the covariates terms and the 
interaction terms between each marker and the covariates are included in the regression 
model as in equation 3. Method 3 will refer to the method using meta-analysis (equation 
4). 
3.3  Results 
Following the quality control steps described in Chapter 2 and the LD-pruning described in 
section 3.2.2, 5,135 SNPs within 3,105 genes remained. All pair-wise interactions between 
those variants (13,181,545 interactions) were calculated using the three methods specified 
above. 
In all three methods, there was no interaction effect, which passed the multiple testing 
correction threshold corresponding to a corrected p-value of 0.05 (Bonferroni threshold 
p=3.79e-9) as shown in Table 3.1. 
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 Method 1 Method 2 Method 3 
Number of interactions with p-value 
below Bonferroni threshold (p=3.79e-9) 
0 0 0 
Number of interactions with p-value p≤1e-
5 
129 138 101 
Number of interactions with p-value 
p≤0.001 
13,586 14,446 10,921 
Lowest observed p-values 7.56e-8 4.62e-8 8.79e-8 
Table 3.1: Number of interactions with a p-value below different thresholds in each 
method. For the three methods, no interaction passed the Bonferroni threshold (p=3.79e-
9). Method 2 detects more interactions below the thresholds 10-5 and 0.001. Method 1 has 
similar results to Method 2, whereas Method 3 detects the least number of interactions 
below a give threshold. 
3.3.1  Computational performance 
When comparing the computational time for the three methods (Table 3.2), Method 3 was 
the fastest with a running time of approximately 2 hours. It used two software packages 
(PLINK and METAL) that are designed and optimised for genetic data processing and 
therefore can run these analyses efficiently. The analyses with Method 1 and Method 2 
took significantly longer (5 days for Method 1 and 1 week for Method 2) for the 
calculations. Both of these methods were implemented in R, which in general is not the 
most efficient statistical software and the running time for these two methods is not 
directly comparable with the running-time of Method 3. 
 Method 1 Method 2 Method 3 
Computational 
methodology 
R script R script PLINK and Metal 
Running time 5 days 1 week 2 hours 
Table 3.2: Running time of each method for the interaction analysis. 
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3.3.2  Distribution of results for the three methods 
Visually comparing the distribution of the calculated interactions p-values between the 
three methods, Q-Q plots from Method 1 and Method 2 look quite similar whereas Method 
3 produced slightly less significant results than we would expect to have by chance at the 
higher significant thresholds (Figure 3.1). 
3.3.3  Correlation between the results from the three methods 
Correlation coefficients were calculated between the three methods, based on all 
interaction p-values for each SNP (Table 3.3).  
 M1 / M2 M1 / M3 M2 / M3 
Pearson 
R 0.964 0.793 0.815 
p-value p<2.2e-16 p<2.2e-16 p<2.2e-16 
Pearson (-log10P) 
R 0.981 0.847 0.861 
p-value p<2.2e-16 p<2.2e-16 p<2.2e-16 
Spearman 
R 0.965 0.793 0.815 
p-value p<2.2e-16 p<2.2e-16 p<2.2e-16 
Table 3.3: Correlation between the three methods. The correlation coefficients were 
calculated with three methods: Pearson, Pearson using a log transformation of p-values 
and Spearman. 
The correlation between Methods 1 and 2 is very high as can also be seen from Table 3.3 
and Figure 3.2 (left panel). When comparing Method 3 with either Method 1 or 2, the 
degree of correlation is reduced, although still high as is shown in Table 3.3 and Figure 3.2 
(middle and right panel). Despite the obvious correlation of p-values with extremely low p-
values, Figure 3.2 also indicates that the interactions with low p-value are correlating well. 
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Figure 3.1: Quantile-quantile (QQ) plots for all pair-wise interactions analysis calculated for each method. The QQ plots show a representation of the deviation 
of the observed p-values (expressed as the negative log of the p value) from the null hypothesis: the observed P values for each interaction (y axis: Observed) 
are sorted and plotted against expected values from a theoretical χ2-distribution (x axis: Expected). λ is the genomic inflation factor and λ1000 the estimated 
genomic control (value that would be expected in a study of 1,000 cases and 1,000 controls). The left panel represents Method 1, the middle panel Method 2 
and the right panel is Method 3. The observed p-values in Method 3 are less significant than expected.  
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Figure 3.2: Scatter plot of interactions p-values using logarithmic scale for Method 1 against Method 2 (left panel), Method 2 against Method 3 (middle panel) 
and Method 1 against Method 3 (right panel).  
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As shown by (Bland and Altman 1986) a strong correlation between two methods does not 
automatically imply agreement between them: correlation coefficients only measure the 
strength of the relationship between two variables. For example, a change of scale will not 
affect the correlation coefficients but will change the agreement. 
Bland Altman plots were used to check the agreement between the results of the three 
methods. This is a simple way of graphically comparing the agreement between two methods. 
It plots the difference between the results calculated by the two methods as a function of the 
average of those two results (Bland and Altman 1986). If the points on the Bland Altman plot 
are randomly distributed, above and below zero, then it is possible to conclude that there is no 
consistent bias of one method versus the other. But for example if one method always gives a 
different results e.g. with all points above or below the zero line, it would be possible to 
conclude that one method over or underestimates the results. However there would be no 
certainty on which one is responsible for the over/underestimation. The three plots in Figure 
3.3 shows the Bland Altman plots respectively for Method 1 against Method 2 (left panel), 
Method 1 against Method 3 (middle panel) and Method 2 against Method 3 (right panel). The 
results are above and below zero in all the cases, which tends to indicate that there are no 
visible biases. However a trend is visible when looking at Method 3 against the other two 
methods (Figure 3.3 middle and right panel), indicating that the difference between the 
methods is reduced when looking at high values (very low p-values as the logarithmic scale is 
used). This would confirm that the overall performance of each method is comparable, with 
closest agreement for the most significant interactions. 
 68 
 
 
Figure 3.3: Bland Altman plots using logarithmic scale to check agreements between the methods: Method 1and 2 (left panel) Method 1 and 3 (middle panel) 
and Method 2 and 3 (right panel). Difference refers to the difference between the results calculated for the two methods. Mean refers to the average of those 
two results. The blue doted lines show the 95 percent confidence intervals. 
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3.3.4  Interaction results with lower p-values 
To further investigate the lower end of the p-value distribution interactions with (both) 
p≤0.001 in each pair of methods were compared (Table 3.4). 
 
 Methods 1 and 2 Methods 1 and 3 Methods 2 and 3 
Number of interactions  
with p≤0.001 in both methods 
11,465 6,733 7,374 
Table 3.4: Number of interactions with a p-value p≤0.001 for each pair of methods. 
 
As can be seen from the scatter plots (Figure 3.4), all the methods produced similar result 
and showed positive correlation. The scatter plot of Method 1 and Method 2 (Figure 3.4, 
left panel) showed the strongest positive correlation. 
The results of the correlation analysis between each pair of methods reflect what is 
observed in the scatter plots (Table 3.5, Results). The correlation coefficients are obviously 
lower than the one previously observed when comparing the whole distributions of 
interactions (Table 3.5, previous results). However when comparing the lower end of the 
distribution, it shows a very strong positive correlation between Method 1 and Method 2 
(Table 3.5, Results). The correlation between Method 3 and Methods 1 and 2 is lower but 
still shows positive correlation (Table 3.5, Results). 
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Previous Results Results 
M1 / M2 M1 / M3 M2 / M3 M1 / M2 M1 / M3 M2 / M3 
Pearson 
R 0.964 0.793 0.815 0.776 0.492 0.546 
p-value p<2.2e-16 p<2.2e-16 p<2.2e-16 p<2.2e-16 p<2.2e-16 p<2.2e-16 
Pearson (-log10P) 
R 0.981 0.847 0.861 0.901 0.675 0.721 
p-value p<2.2e-16 p<2.2e-16 p<2.2e-16 p<2.2e-16 p<2.2e-16 p<2.2e-16 
Spearman 
R 0.965 0.793 0.815 0.805 0.545 0.595 
p-value p<2.2e-16 p<2.2e-16 p<2.2e-16 p<2.2e-16 p<2.2e-16 p<2.2e-16 
Table 3.5: Correlations between the three methods after selecting interactions with a p-value p≤0.001 in each method. The correlation coefficients were 
calculated with three methods: Pearson, Pearson using a log transformation of p-values and Spearman. 
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Figure 3.4: Scatter plots of interactions with p-values (log scale) below 0.001 selected in each pair of methods. Method 1 against Method 2 (left panel), Method 
1 against Method 3(middle panel), Method 2 against Method 3 (right panel). All scatter plots show positive correlation.  
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3.3.5  Investigation of differences between methods 
This section is focused on interactions that are identified as below the threshold (p≤0.001) 
in at least one method and more specifically on interactions passing that threshold in one 
method but not in another method. In addition, it explores one of the potential 
explanations for the differences observed. Other approaches that were not explored due 
to lack of time will be detailed in the discussion section. 
In each pair of methods compared, interactions were selected if in at least one of the two 
methods the p-value was below the threshold p≤0.001 (Table 3.6). 
 Methods 1 or 2 Methods 1 or 3 Methods 2 or 3 
Number of interactions with 
p≤0.001 in at least one method 
16,563 17,770 17,989 
Table 3.6: Number of interactions with a p-value p≤0.001 in one of each pair of methods. 
 
As previously, scatter plots were drawn to observe the distribution of p-values in each 
method (Figure 3.5). Compared to previous section (Figure 3.4), interactions with a p-value 
below the threshold in both methods were removed. Comparison between Method 1 and 
Method 2 (Figure 3.5, left panel) produced results very similar to those previously 
observed, with no major differences between the two methods. Comparing Method 3 with 
the other two methods, the scatter plots (Figure 3.5, middle and right panels) looks 
different. In some cases, Method 3 is able to identify interactions with reasonably low p-
values and the other method does not. In other cases, the opposite is observed.  
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Figure 3.5: Scatter plots of interactions with p-values (log scale) below 0.001 selected in each method. Method 1 against Method 2 (left panel), Method 1 
against Method 3(middle panel), Method 2 against Method 3 (right panel). The first scatter plot of Method 1 and Method 2 shows positive correlation. The 
other scatter plots Method 1 and Method 3 (middle panel) Method 2 and Method 3 (right panel) are more different but interactions with very low p-values 
have closer results. 
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3.3.5.1  Role of the direction of effects  
The software METAL, used in Method 3, calculated the direction of the effect for each 
study. Since only interaction terms were meta-analysed, the direction of the main effects 
was ignored. In the present analysis, as there are 8 different studies that are combined, 
the number of identical direction of effects varies between 4 and 8. Scatter plots (Figure 
3.6) were drawn to investigate whether or not the direction of the interaction effects could 
explain the observed results (Figure 3.5). This showed that when the directions of effect 
are identical in four or five out of 8 studies, Method 3’s results are different from Methods 
1 and 2 (Figure 3.6 A, B, D and E). However when the directions of effect are uniform across 
the 8 studies, Method 3 produces results that more closely match those of the other 
methods (Figure 3.6, C and F). This indicates that the direction of the interaction effect 
might be playing a role in Method 3’s results. Perhaps taking into account the SNPs main 
effects could enhance this method.  
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Figure 3.6: Scatter plots of interactions with p-values below 0.001 selected in at least one 
method. Method 1 against Method 3 (left panel), Method 2 against Method 3 (right 
panel). In A and D plots, the black dots show interactions where the direction of effects is 
different in 4 samples out of 8. In B and E plots, the black dots show interactions where 
the direction of effect is the same in four or five samples out of 8. In C and F plots the blue 
dots show interactions where the direction of effect is identical in all the samples. All 
graphs show that the direction of interaction effects might play a role in explaining 
Method 3’s results. 
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3.4  Discussion 
3.4.1  Multiple testing 
No interactions survived Bonferroni correction for multiple testing in any analysis 
performed using the three methods. As the number of calculated interactions is very high, 
the penalty for multiple testing is severe (Bonferroni threshold p=3.70e-9). 
One possible explanation for the absence of significant interactions could be the sample 
size: the ISC dataset contains 3,322 cases and 3,587 controls. A bigger sample would 
increase the statistical power as shown by (Gauderman 2002) and as will be detailed in the 
next Chapter. 
3.4.2  Correlation between the results of the three methods 
Methods 1 and 2 were found to have extremely similar result: the correlation coefficient 
between the results of the two methods is close to the perfect linear association 
(correlation almost equal to 1) indicating a strong positive relationship between both 
approaches (Table 3.3). Method 1 only adds the covariates into the primary equation (see 
Equation 2). Method 2 differs from Method 1 by the fact it deals with the bias explained 
by Yzerbyt et al. (2004): it takes into account the possible effect between the covariates 
and each marker by adding interactions terms between covariates and markers into the 
equation (see Equation 3). As the presented results between those two methods are 
comparable, it seems that the bias mentioned above does not play a large role, at least in 
the analysed dataset. However, a large-scale simulation study would be needed in order to 
definitely prove this assertion. 
The correlation between Method 3 and the other methods (Method 1 and Method 2) 
appears to be quite high as well (Table 3.3). It also showed that interactions with low p-
value (i.e. greater significance) seem to be moderately well correlated (Figure 3.2). 
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Scatter plots and Bland Altman agreements plots between the results of the three methods 
showed very strong relationship between Method 1 and 2, and less strong but good 
association between Method 3 and the other two methods. In addition, the Bland Altman 
agreements plots do not show evidence of bias of one method versus the other as the 
observed values tend not to be consistently above or below zero. This confirmed the results 
observed by looking only at the correlation coefficients (Table 3.3).  
3.4.3  Interactions with lower p-values 
As the interest in this analysis was focused on significant results, the lower tail of the 
distribution of p-values was examined in more detail. 
When selecting interactions with a p-value below the threshold p≤0.001 in each method, 
it was observed that Method 1 and 2 again produced similar results: the correlation 
coefficients were high (Table 3.5) and the scatterplot shows a strong positive relationship 
between the two approaches (Figure 3.4, left panel). Some differences were visible 
between Method 3 and the other two methods (Figure 3.4, middle and right panel): 
Method 3, which uses the meta-analysis, did not identify as many interactions with a p-
value p≤0.001 as the other methods (Table 3.4). However, the calculated correlation 
coefficient between Method 3 and Methods 1 and 2 showed positive correlation (Table 
3.5).  
3.4.4  Differences observed at the lower end of the distribution 
When investigating interactions with a p-value below the threshold p≤0.001 in either 
method, two main observations were made. First, there is no major difference between 
Methods 1 and 2. Secondly, when comparing Method 3 with the other two methods, 
differences were observed. In some cases, Method 3 was able to identify interactions with 
reasonably low p-values while the other method (Method 1 or Method 2) was not, and vice 
versa. 
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Several explanations can be given for this observation. Firstly, differences in the direction 
of interaction effect between populations could be a factor influencing the model used by 
Method 3. When the direction of the interaction effect was investigated, it was found that 
when the direction of effect was identical in only four or five out of eight studies, Method 
3’s results tended to differ most from those of Methods 1 and 2.  
A second hypothesis is that this observation is due to an over-estimation of the results by 
Method 3. Method 3 uses METAL for the meta-analysis but only meta-analyse the 
interaction term, ignoring the two SNP main-effects. In contrast, Method 1 and 2 take into 
account the main effects. It is possible that not including the main effects results into an 
over-estimation of the interaction effect size in Method 3, as it may lead to the interaction 
term capturing some of the main SNP effects. To investigate this, a multivariate approach 
taking into account the covariance between the SNPs main effects and the interaction 
effects could be used. Further work would include the application of a different meta-
analysis method, such as the one described in Van Houwelingen et al. (2002), to account 
for this and to see if this ameliorates the results. 
3.4.5  Covariates, power and epistatic model 
The power of interaction detection in statistical analysis can be influenced by many factors 
such as the increase of sample size or the inclusion of covariates (Sham and Purcell 2014). 
Often the inclusion of appropriate covariates into linear regression models leads to 
improved power of detection (Sham and Purcell 2014). However there is one interesting 
exception for case control studies in complex diseases: including covariates into a logistic 
regression model can result in a loss of power of detection when the disease prevalence is 
low (Pirinen et al. 2012). Potentially this can be translated to gene-gene interactions and 
raises the question of the need to adjust for covariates. However if the covariates are well 
known confounds, such as population structure, there is a need to introduce them to 
properly control for their effects and thus accepting the loss of power. 
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Furthermore the choice of scale is crucial. The scale depends on a link function that models 
the relationship between the phenotype and the predictors (Frånberg et al. 2015): in this 
thesis the logistic regression was used. The choice of link function has important 
implications: it can impact on the definition and interpretation of epistasis (Clayton 2012). 
Indeed, Clayton (2012) argued that the logistic regression model with no statistical 
interaction between genes is quite strongly epistatic. 
Ultimately the choice of scale is problematic as it depends on the data and its underlying 
biological model, which is unknown (Frånberg et al. 2015). For this reason it is possible to 
choose a scale that would reveal interaction despite having a biological model that does 
not present any interaction (Clayton 2012). On the other hand, a true interaction effect 
would be weakened by an inappropriate choice of scale (Frånberg et al. 2015).  
For this reason further work could include the use of different link functions in order to 
investigate this issue: assuming true interactions in the biological model, the detection of 
such interactions should not depend on the choice of scale (Frånberg et al. 2015; Knol and 
VanderWeele 2012). 
3.4.6  Summary of the chapter 
This chapter compared three different ways to include covariates in an interaction analysis. 
The comparison presented showed that the overall performance of the three methods is 
similar. No evidence of bias in one method versus the other was observed as seen through 
the Bland Altman and scatter plots. 
Efficiency and running time is a strong factor in the choice of the method to use. Method 
3 is the simplest and most efficient method by far compared to the other two methods. In 
addition, Method 3 is extremely memory efficient making it the easiest and fastest method 
to carry out interaction analysis for thousands of SNPs. This supports the use of Method 3 
to perform SNP-SNP analyses in Chapter 4 and 5. The possible influence of the direction of 
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interaction effects in the samples will not be addressed in the following chapters as work 
exploring that effect was done a posteriori. 
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Chapter 4 -  Interactions in GWAS datasets 
4.1  Introduction 
4.1.1  Background 
Genome-wide association studies (GWAS) have demonstrated that there are hundreds of 
loci associated with schizophrenia (Schizophrenia Working Group of the Psychiatric 
Genomics Consortium 2014). In addition CNVs and rare variants studies have also shown 
evidence of association with the disease (Rees et al. 2014). However the cumulative effects 
of these findings only account for a minority of the heritability of schizophrenia (Sullivan et 
al. 2003): there are indications that some of the unexplained heritability may be attributed 
to interactions between loci (Zuk et al. 2012).  
Evidence for genetic interactions has been reported in many model organisms including 
for the prediction of complex traits (Bloom et al. 2013; He et al. 2010; Mackay 2013; 
ÁLvarez-Castro et al. 2012). Many methods have been developed to identify genetic 
interactions in human GWAS data (Wei et al. 2014): several large-scale interaction studies 
have now evaluated evidence for interactions genome-wide for several complex disorders 
(Wei et al. 2012; Moskvina et al. 2011; Prabhu and Pe’er 2012). Among those studies, only 
a few interactions have reached an appropriate level of significance and have been 
replicated (Hemani et al. 2014; Chu et al. 2014) .  
Genome-wide interaction studies have been quite unexplored in schizophrenia. A few 
studies have provided evidence supporting a role for gene-gene interactions in 
schizophrenia (Nicodemus et al. 2010; Burdick et al. 2008). In this chapter the focus is 
drawn on disease associated pair-wise interactions through exhaustive genome-wide 
testing. 
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4.1.2  Aim of the chapter 
The main aim of this chapter is to assess SNP-SNP interactions in two non-overlapping 
GWAS dataset (ISC and CLOZUK). Two interaction analyses will be presented: one using 
SNPs specific to each dataset and the other one will be restricted to the SNPs common to 
both dataset. 
The second aim of this chapter is to investigate whether genetic information alone could 
be used to identify sets of genes enriched for interactions.  
4.2  Material and Methods 
4.2.1  Data 
The datasets used were the CLOZUK dataset (Hamshere et al. 2013) and ISC studies 
(International Schizophrenia Consortium 2008). CLOZUK consists of a total of 5,200 
individuals with schizophrenia and 5,987 healthy subjects. ISC consists of 3,322 cases and 
3,587 controls. The data, including the quality control steps applied to it, are described in 
Chapter 2. 
4.2.2  Method and hypothesis 
The method used to calculate SNP-SNP interactions was described in detail in Chapter 3: 
Method 3. SNP-SNP interactions are calculated independently in each sub-datasets using 
PLINK 1.9 (Purcell et al. 2007; Chang et al. 2015) and the meta-analysis tool METAL (Willer 
et al. 2010) combines the results. Only the interaction terms are meta-analysed: 
interaction p-values are independent from the main effects.  
This chapter investigates if genetic information (in the form of SNP main effects) can help 
to identify group of genes enriched for ‘significant’ interactions. Pairwise SNP-SNP 
interactions were calculated then ranked by the gene wide (main effect) significance of the 
genes involved: the highest ranking SNP-SNP interactions will be those linked to genes 
highly associated with schizophrenia and the lowest ranking SNP-SNP interactions will be 
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those linked to genes least associated with the disease. The distribution of interaction p-
values in high- and low-ranking gene pairs was compared to assess the evidence for an 
enrichment of SNP-SNP interactions within gene pairs most highly associated with the 
disease. 
4.2.3  SNP selection 
Firstly, only SNP inside genes were kept. The present work is focusing on interactions 
between SNPs: insertions and deletions (in-dels) were excluded from the analysis due to 
their rarity as well as the inaccuracy of their calling (Hasan et al. 2015). 
Secondly, the analysis focuses on autosomal chromosomes: all variants on X and Y 
chromosomes were removed as a separate analysis of male and female would have been 
needed. In addition, a separate analysis would have led to a smaller sample size and 
resulted in a loss of power for detection.  
 For the common-SNP comparison, a supplementary step was added: the selection of SNPs 
present in both datasets. 
4.2.4  Clumping procedure 
As detailed in Chapter 1, section 1.2.3, getting enough power to identify significant 
interactions between correlated variants is unlikely: the inclusion of every variant in the 
interaction analysis would massively increase the multiple testing burden (under simple 
Bonferroni type correction) (Moskvina et al. 2011). Moreover it is important to prevent 
collinearity problems that can arise when SNPs are highly correlated (see Chapter 3, section 
3.2.2) 
For these reasons linkage-disequilibrium (LD) pruning was used to reduce the number of 
SNPs involved in the analysis: the most highly associated SNPs were selected and any other 
SNPs in LD with them were removed.  
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In addition all the SNPs within the major histocompatibility complex (MHC) region were 
excluded due to extensive LD in that specific region (Price et al. 2008). 
In the independent analysis where SNPs specific to each dataset are used, ISC and CLOZUK 
were clumped separately. The same parameters were chosen for the window and the R-
square threshold (Table 4.1). However due to the high difference of number of variants 
after QC in each dataset (Chapter 2), different parameters were used for the significance 
threshold p1 (Table 4.1) to obtain a similar number of SNPs within each dataset. 
For the common-SNPs analysis, only the CLOZUK dataset was clumped, as it has a larger 
number of cases and controls than the ISC dataset. The parameters used were the same 
as previously indicated (Table 4.1). 
Clumping parameters Independent analysis Common-SNPs analysis 
ISC CLOZUK ISC CLOZUK 
Window w in kb 2,000 2,000 NA 2,000 
R-square threshold r2 0.1 0.1 NA 0.1 
Significance threshold p1 0.1 0.01 NA 0.01 
Table 4.1: Clumping parameters used in the two analyses: window, R-square threshold 
and significance threshold. The Independent analysis refers to the interaction analysis 
performed using SNPs specific to each dataset. The common SNPs analysis refers to the 
interaction analysis that used SNPs common to both datasets: the clumping was 
performed only on the CLOZUK dataset. NA: Not applicable. 
4.2.5  SNP-SNP interaction analysis 
In this chapter, statistical interactions were calculated using a logistic regression model 
that estimates the disease status of individuals as a function of independent predictor 
variables corresponding to the genotypes of the considered markers. The method used to 
calculate SNP-SNP interactions was previously described in details in Chapter 3 section 
3.2.3.3. Briefly, the 8 different sub-populations in the ISC dataset as well as the two chips 
in CLOZUK were analysed separately using PLINK 1.9 (Purcell et al. 2007; Chang et al. 2015). 
The results were then combined by means of inverse variance meta-analysis for each 
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dataset using METAL (Willer et al. 2010). The interaction p-values are independent from 
the main effects as only the interaction terms are meta-analysed. 
4.2.6  Ranking of the interactions 
Gene wide significance for each gene was calculated using Brown’s method (Brown 1975). 
This approach is derived from Fisher’s statistics and allows combining p-values from 
dependent results. In order to calculate the gene-wide significance for each gene, the 
method combines the association p-values of every SNP for that gene taking into account 
the number of SNPs and the degree of LD between them (Moskvina et al. 2011). The 
resulting p-value reflects the overall degree of association between SNPs in this gene and 
disease. 
SNP-SNP interactions were then ranked using the gene-wide p-values for the 
corresponding genes.  If the interaction involved two SNPs in the same gene, the gene-
wide p-value of this gene was used. When the interaction involved two SNPs from two 
different genes, Fisher’s method was used to combine the gene-wide p-values from the 
two genes as shown in the following equation: 
−2 ∑ log (
𝑘
𝑖=1
𝑝𝑖) ~𝜒2𝑘
2  
with 𝑝𝑖  representing the gene wide p-values for the gene 𝑖 and 𝑘 is the number of genes 
being combined (here k = 2). As a result, the highest-ranking SNP-SNP interactions are 
those corresponding to pairs of genes most highly associated with the disease, whereas 
the lowest ranking SNP-SNP interactions are those linked to genes least associated with 
the disease. 
To check for potential confounding factors, the interactions were also ranked by gene-wide 
p-values from other psychiatric disorders: Alzheimer disease (Lambert et al. 2013), 
Parkinson disease (Nalls et al. 2014) and Bipolar disorder(Psychiatric GWAS Consortium 
Bipolar Disorder Working Group 2011). The Alzheimer disease GWAS (Lambert et al. 2013) 
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was a large, two-stage meta-analysis of individuals from European ancestry: it used 
genotyped and imputed data for 17,008 cases and 37,154 controls in stage one and 
genotyped data in 8,572 cases and 11,312 controls for stage 2 and identified 19 variants 
associated with the disease. The Parkinson disease GWAS (Nalls et al. 2014) was a meta-
analysis of 13,708 cases and 95,282 controls using genotyped and imputed variants: it 
identified 28 independent loci linked to the disease. The Bipolar Disorder GWAS 
(Psychiatric GWAS Consortium Bipolar Disorder Working Group 2011) used 11,974 cases 
and 51,792 (combining discovery and replication set) and identified 34 SNPs associated 
with the disease, among which 18 replicated.  
In addition the interaction results from one dataset were ranked by the gene-wide 
significance from the other dataset: the CLOZUK interactions were ranked using the ISC 
gene-wide p-values and vice versa. Finally interactions in both dataset were also ranked by 
gene-wide p-values calculated from the Psychiatric Genomics Consortium 2 GWAS SNP 
association statistics (Schizophrenia Working Group of the Psychiatric Genomics 
Consortium 2014). 
4.2.7  Testing for enrichment 
4.2.7.1  Testing the full interaction distribution 
To test the hypothesis that interactions are more likely to occur within genes associated 
with schizophrenia, a Spearman rank correlation test was performed between the 
interaction p-values and the corresponding (combined) gene-wide significance p-value. 
To further investigate the hypothesis, a linear regression was used as described in the 
following equation.  
 
Let 𝐺𝑊𝑃𝑙𝑜𝑔10  be the Fisher's combined gene-wide p-values (-log10) as described in 
section 4.2.6  . 
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Let 𝑃𝑙𝑜𝑔10 be the interaction p-values (-log10). 
Let 𝑁𝐵𝑆𝑁𝑃 be the number of variants in the genes involved in the interaction. 
Let 𝐿𝑒𝑛𝑔𝑡ℎ𝑔𝑒𝑛𝑒𝑠 be the length of the genes involved in the interaction. 
Let 𝛽𝑖 the standardized beta coefficients: 𝛽0 is the Y-intercept. 
Let 𝜀 be the random error component. 
𝐺𝑊𝑃𝑙𝑜𝑔10~𝛽0 + 𝛽1𝑃𝑙𝑜𝑔10 + 𝛽2𝑁𝐵𝑆𝑁𝑃 + 𝛽3𝐿𝑒𝑛𝑔𝑡ℎ𝑔𝑒𝑛𝑒𝑠 + 𝜀 
The linear regression model will assess whether SNPs from genes with greatest disease 
effects (largest 𝐺𝑊𝑃𝑙𝑜𝑔10 values) tend to have more significant interactions (larger 𝑃𝑙𝑜𝑔10) 
while taking into account the number of SNPs and the length of each gene. 
4.2.7.2  Testing with prior selection of interactions 
To further compare interactions between associated genes to those between non-
associated genes, a one-sided Wilcoxon Mann Whitney test was used on the ranked SNP-
SNP interactions: the top N% of SNP-SNP interactions (‘top’ referring to interactions 
involving genes most highly associated with schizophrenia) was tested against the bottom 
N% of SNP-SNP interactions (‘bottom’ referring to interactions involving genes that are 
least associated with schizophrenia), with N varying from 1% to 50%. This test compares 
the distribution of SNP-SNP interaction p-values between SNPs in ‘top’ genes (highly 
associated with schizophrenia) to the distribution of SNP-SNP interaction p-values between 
SNPs in ‘bottom’ genes (those least associated with disease). 
To further quantify the observed effect, ratios were calculated of the number of SNP-SNP 
interactions with p-value p < α in ‘top’ genes to the number of interactions with p-value p< 
α in ‘bottom’ genes for a range of significance thresholds α. This provided more detail on 
the level of significance driving the effect. A ratio above one would indicates an excess of 
SNP-SNP interactions with P < α in the set of ‘top’ genes. 
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4.2.8  Network of SNP-SNP interactions 
To further assess interactions between associated genes to those between non-associated 
genes, networks were drawn to visualise and compare links between the two groups of 
ranked interactions: the top N% of SNP-SNP interactions (‘top’ referring to interactions 
involving genes most highly associated with schizophrenia) against the bottom N% of SNP-
SNP interactions (‘bottom’ referring to interactions involving genes that are least 
associated with schizophrenia), with N varying from 1% to 50%. In both groups, SNP-SNP 
interactions with a p-value p<0.01 were selected.  
While many SNP-SNP interactions with a p-value p < 0.01 are likely to be false positive, it is 
possible that a proportion of SNPs could potentially contribute to multiple true interactions 
and therefore be of interest. 
The network comparison was done at both the SNP and the gene level. In figures illustrating 
these networks, each SNP (or gene) is represented by a node and interactions with p < 0.01 
between two SNPs (or genes) are represented as a link between the corresponding nodes.  
To further assess the networks, the Database for Annotation, Visualization and Integrated 
Discovery (DAVID) (Sherman et al. 2007) was used to investigate shared biological 
processes (GO terms) between genes (Ashburner et al. 2000). 
4.2.9  Functional annotation of significant interactions 
Genes involved in interactions with an interaction p-value p < 10-4 were further examined 
(genes sizes were not taken into account) The biological functionalities of those genes were 
analysed using the DAVID (Sherman et al. 2007). The background list of genes was built 
with the genes from the interaction that did not pass the selection threshold. For the 
functional annotation, it was decided to use the summarised version of the Biological 
processes in the Gene Ontology (Ashburner et al. 2000). A modified Fisher’s exact test was 
used to determine whether genes involved in interactions with an interaction p-value p < 
10-4 were enriched for GO terms compared to a background list of genes. An enrichment 
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threshold was chosen for p=0.05: an annotation category is considered of interest at that 
threshold (Sherman et al. 2007). The analysis was performed on the results for the 
independent comparison as well as on the ones form the common-SNPs comparison. 
4.3  Results 
4.3.1  Overall assessment of the interaction analyses 
For the independent analysis, each dataset was studied separately. Out of the SNPs present 
in all 8 subpopulations of the ISC dataset, 2,898 SNPs within 2,080 genes were left after 
linkage disequilibrium pruning (Table 4.3). All pair-wise interactions were assessed 
separately for each population using logistic regression analysis and then combined by 
meta-analysis (Figure 4.1). No interaction survived the multiple test correction (Table 4.3). 
Similarly after LD pruning, 3,318 SNPs within 2,418 genes remained out of the selected 
SNPs in the CLOZUK dataset (Table 4.2). All possible pair-wise interactions were calculated 
separately for each chip and combined as explained previously. Once again, none of the 
interactions passed a Bonferroni corrected p-value threshold of 0.05 (Table 4.3). 
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Figure 4.1: Quantile-quantile plots for all pair-wise interactions analysis calculated for 
each dataset. The top panels show the independent SNPs analysis for the ISC (top left) and 
the CLOZUK (top right) datasets. The bottom panels show the common-SNPs analysis for 
the ISC (bottom left) and the CLOZUK (top right) datasets. 
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Independent analysis Common SNPs analysis 
ISC CLOZUK ISC CLOZUK 
Number of SNPs before LD 
pruning  
92,860 1,751,178 71,038 71,038 
Number of SNPs after LD 
pruning 
2,898 3,318 4,318 4,318 
Number of associated genes  2,080 2,418 2,791 2,791 
Number of calculated 
interactions 
4,197,753 5,502,903 9,320,403 9,320,403 
Table 4.2: Number of SNPs (before and after LD pruning), number of associated genes and 
number of calculated interactions in the two analyses (Independent and common-SNPs) 
for each dataset. 
For the common-SNPs analysis, after selecting the common variants between the two 
populations, 71,038 SNPs remained. LD pruning was performed on the larger sample 
(CLOZUK) resulting in the selection of 4,318 SNPs within 2,791 genes that were used to 
perform the pair-wise analysis (Table 4.2). Out of the calculated interactions, none survived 
Bonferroni correction in either dataset (Table 4.3). 
 
 
Independent analysis Common SNPs analysis 
ISC CLOZUK ISC CLOZUK 
Smallest observed p-value 6.15e-7 1.47e-6 2.02e-08 9.06e-08 
Bonferroni Threshold 1.19e-8 9.09e-9 5.36e-09 5.36e-09 
Number of interactions below 
the Bonferroni Threshold 
0 0 0 0 
Table 4.3: Smallest interaction p-value, Bonferroni threshold and number of calculated 
interactions below that threshold in the two analyses (Independent and common-SNPs) 
for each dataset. None of the interactions passed the Bonferroni threshold correction. 
4.3.2  Ranking the interactions 
4.3.2.1  Ranking by gene-wide p-values linked to each dataset 
As detailed in section 4.2.6, interactions were first ranked by gene-wide significance 
calculated in the same dataset.  
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4.3.2.1.1  Spearman ranked correlation 
Spearman ranked correlation coefficients were calculated between interaction p-values 
and the combined gene-wide significance of the genes involved in each interaction (Table 
4.4). While both independent analyses showed a significant relationship between 
interaction p-values and gene-wide significance, the correlation was very small (Table 4.4) 
and probably only detected due to the very high number of degrees of freedom. For the 
common-SNPs analyses the correlation coefficient was either extremely low (CLOZUK) or 
low and negative (ISC) with non-significant p-values, indicating no relationship between 
the interaction p-values and gene-wide significance. 
 Independent 
analysis 
Common-SNPs 
analysis 
ISC CLOZUK ISC CLOZUK 
Spearman ranked 
correlation R 2.36e
-3 5.14e-3 -1.63e-04 2.72e-04 
P-value 1.36e-6 2.2e-16 0.618 0.406 
Table 4.4: Spearman ranked correlation calculated for each dataset (ISC and CLOZUK) in 
both analyses (Independent and common-SNPs) between the interaction p-values and the 
gene-wide p-values. 
 
4.3.2.1.2  Linear Regression Model 
To assess whether SNPs from genes with greatest disease effects tend to have more 
significant interactions, a linear regression model taking into account the number of 
variants per genes and the length of the gene was used. For the independent analysis, the 
adjusted R-square (Table 4.5) showed that a small part of the variance in the gene-wide 
significance variable can be explained by the predictor variables (SNP-SNP interaction p-
values, number of SNPs and length of each gene). In addition it was found that the 
interaction p-values were significant predictors but did not play a big role. However for the 
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common SNPs analysis, the adjusted R-square are very low and the interaction p-values 
are not significant predictors (Table 4.5). 
 
 
 Independent 
analysis 
Common-SNPs 
analysis 
ISC CLOZUK ISC CLOZUK 
Adjusted R-squared 
0.107 0.0726 1.131e-3 0.0436 
Coefficient for 
interaction p-
values 
Estimate 4.37e-3 6.88e-3 1.05e-3 5.07e-04 
P-value 1.23e-3 3.15e-10 0.141 0.435 
Table 4.5: Adjusted R-squared, beta coefficient for interaction p-values in the linear 
regression. 
4.3.2.1.3  Ranking test 
As explained in section 4.2.7 a one-sided Mann Whitney Wilcoxon ranking test was used 
to quantify the over-representation of small interactions p-values within the most highly 
schizophrenia associated genes compared to interactions within genes least associated 
with the disease. 
The comparison was done in both analyses (Figure 4.2): the independent analysis and the 
common SNPs analysis. In the independent analysis, the over-representation p-values 
were significant in both ISC and CLOZUK datasets (Figure 4.2, top panel) indicating an 
excess of significant interactions within the genes that are most highly associated with the 
disease. The effect was much more pronounced for the CLOZUK dataset than it was for the 
ISC dataset (Figure 4.2, top panel). In the common-SNPs analysis the over-representation 
p-values were not significant in both ISC and CLOZUK datasets (Figure 4.2, bottom panel) 
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Figure 4.2: Histograms of the ranking test (-log10(p-value)) for the independent analyses 
(top panel) and the common SNPs analysis (bottom panel) for both datasets (ISC and 
CLOZUK). This test compares the distribution of N% SNP-SNP interaction p-values between 
SNPs in genes highly associated with schizophrenia to the distribution of N% SNP-SNP 
interaction p-values between SNPs in genes least associated with disease. GWP refers to 
gene-wide p-value. The red line shows the multiple test significance thresholds for a 
corrected p-value of 0.05 (Bonferroni correction p-value p=0.0022). An excess of 
significant interactions within the genes that are most highly associated with the disease 
is observed for ISC and CLOZUK in the independent analysis (top panel).
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4.3.2.2  Ranking by gene-wide p-values from the other dataset and the PGC 
In this section, interactions were ranked by gene-wide significance of the corresponding 
genes as calculated in the other dataset (CLOZUK interactions ranked by gene-wide p-
values calculated in the ISC dataset and vice versa) and from the Psychiatric Genomics 
Consortium 2 (PGC2). The ISC and CLOZUK datasets are both part of the PGC2 dataset. 
(Schizophrenia Working Group of the Psychiatric Genomics Consortium 2014). As in the 
previous section ranking was done for both analyses (independent and common-SNPs) to 
compare the results (Figure 4.3).  
In the independent analysis when ranking interactions from the CLOZUK dataset using the 
gene-wide p-values calculated for the ISC dataset (and vice versa), the enrichment for 
significant interactions disappeared in both cases (Figure 4.3, top panel) However when 
ranking by the gene-wide p-values calculated for the PGC2 dataset (which contains both 
ISC and CLOZUK data), in both ISC and CLOZUK dataset an enrichment is detected. 
In the common-SNPs analysis, only when ranking interactions from the ISC dataset using 
gene-wide p-values from CLOZUK was enrichment observed in some cases (35%, 40% and 
45% of the distribution) (Figure 4.3, bottom panel). 
Furthermore, comparison of correlation coefficients between the ISC, CLOZUK and PGC2 
gene-wide significance p-values (Table 4.6) revealed low correlation between the ISC and 
CLOZUK. The strongest observed relationship is between the CLOZUK and PGC2 gene-wide 
significance (R=0.294). 
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Figure 4.3: Histograms of the ranking test ((-log10(p-value)) for the independent analyses 
(top panel) and the common SNPs analysis (bottom panel) for both dataset (ISC and 
CLOZUK). The ISC interactions were ranked by ISC, CLOZUK and PGC2 GWP. The CLOZUK 
interactions were ranked by CLOZUK, ISC and PGC2 GWP. GWP=gene-wide p-value. The 
black line shows the multiple test significance thresholds for a corrected p-value of 0.05 
(Bonferroni correction p-value p=0.0015). An excess of significant interactions within the 
genes that are most highly associated with the disease is observed for ISC and CLOZUK in 
the independent analysis (top panel) when ranking by the GWP (gene-wide p-value) from 
the dataset (ISC for ISC and CLOZUK for CLOZUK) or from the PGC2.  
Correlation between: ISC and 
CLOZUK GWP 
ISC and 
PGC2 GWP 
CLOZUK and 
PGC2 GWP 
Pearson 
correlation 
R 0.049 0.109 0.272 
P-value 5.20e-9 <2.2e-16 <2.2e-16 
Spearman 
rank 
correlation 
R 0.049 0.128 0.294 
P-value 6.85e-9 <2.2e-16 <2.2e-16 
Table 4.6: Calculated correlation coefficients (Pearson and Spearman) between the gene-
wide significance p-values (GWP) of ISC, CLOZUK and PGC2.  
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4.3.2.3  Ranking by SNP p-values 
To investigate whether SNP-SNP interaction p-values were influenced by the SNP p-values, 
a similar ranking by the SNP p-values was performed (Figure 4.4). In the independent 
analysis, when ranking interactions in the CLOZUK dataset by SNP p-values (Figure 4.4, top 
right) an enrichment was consistently detected. In the ISC dataset, enrichment was only 
observed when comparing 35 and 40% of interactions in high ranked genes with 
interactions in low ranked genes (Figure 4.4, top left). In the common-SNPs analysis, no 
enrichment was detected in either dataset (Figure 4.4, bottom). 
 
Figure 4.4: Histograms of the ranking test (log scale) for the independent analyses (top 
panel) and the common SNPs analysis (bottom panel) for both dataset (ISC and CLOZUK). 
GWP refers to gene-wide p-value. The ISC interactions were ranked by ISC GWP and the 
SNP association p-values. The CLOZUK interactions were ranked by CLOZUK GWP and the 
SNP association p-values. GWP=gene-wide p-value. The black line shows the multiple test 
significance thresholds for a corrected p-value of 0.05 (Bonferroni correction p-value 
p=0.0015). 
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4.3.2.4  Ranking by gene-wide p-values from other disorders 
The ability of gene-wide p-values to identify genes enriched for nominally associated 
interactions suggests that disease-relevant interactions are indeed more likely to occur 
between genes themselves associated with the disorder but also that some interactions 
are specific to each dataset. To investigate whether this result could instead be driven by 
confounding factors (e.g. differences in SNP density or genotyping quality) present in 
GWAS data but unrelated to disease, interactions were re-ranked using gene-wide p-values 
from other neuro-psychiatric/-degenerative disorders: Alzheimer Disease (Lambert et al. 
2013), Parkinson Disease (Nalls et al. 2014) and Bipolar Disorder (Psychiatric GWAS 
Consortium Bipolar Disorder Working Group 2011). Of these, only Bipolar Disorder is 
known to have a strong genetic overlap with schizophrenia (Lichtenstein et al. 2009). 
Assuming the effect to be genuine, Bipolar Disorder gene-wide p-values might potentially 
have the ability to identify genes enriched for schizophrenia-associated interactions.   
In the independent analysis, when ranking the interactions results of the ISC dataset using 
the gene-wide association p-values from Alzheimer Disease and Parkinson Disease, no 
enrichment was observed (Figure 4.5, top left). However, there was an enrichment of 
significant interactions when ordering the interactions using gene-wide p-values for Bipolar 
Disorder (Figure 4.5, top left). The observed effect was the strongest when N=10% (p-
value=3.72e-4). When ranking interactions calculated on the CLOZUK dataset, no ranking 
test passed the multiple correction threshold for a corrected p-value of 0.05, the smallest 
p-value occurring when ranking by the Parkinson gene-wide p-value (p-value=2.21e-3 when 
N=35%). 
In the common-SNPs analyses, when ranking the interaction from the ISC dataset using 
gene-wide p-values form other psychiatric disorders, no test was significant; the same was 
observed in the CLOZUK dataset (Figure 4.5, bottom). Consequently this shows that  the 
observed results are probably not due to confounding factors inherent to GWAS data. 
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Figure 4.5: Histograms of the ranking test (log scale) for the independent analyses (top 
panel) and the common SNPs analysis (bottom panel) for both dataset (ISC and CLOZUK). 
The interactions were ranked by Alzheimer disease, Bipolar disorder and Parkinson 
Disease GWP. GWP refers to gene-wide p-value. The black line shows the multiple test 
significance thresholds for a corrected p-value of 0.05 (Bonferroni correction p-value 
p=0.0015). For the independent analysis, using the ISC dataset, an excess of significant 
interactions within the genes that are most highly associated with the Bipolar Disorder is 
observed. 
4.3.2.5  Ratios  
To further quantify the enrichment effect observed in the independent analysis, ratios of 
the number of interactions below a significance level α were computed. As for the ranking 
test, the ranked SNP-SNP interactions were divided in two groups: N% of the ‘top’ SNP-SNP 
interactions (top referring to interactions involving genes most highly associated with the 
disease) and N% of the ‘bottom’ SNP-SNP interactions (bottom referring to interactions 
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involving genes least highly associated with schizophrenia), N varying from 1% to 50%. 
Then, interactions with a p-value below the significance level α were counted in each group 
in order to calculate the ratio between them. This provided more detail on the level of 
significance driving the effect: a ratio above 1 indicates an excess of interactions with a p-
value below the significance level α within interactions in high ranked genes compared to 
interactions in low ranked genes (Figure 4.6). 
When comparing interaction ratios in both the CLOZUK and ISC datasets, there was an 
excess of interactions below the significance level α in high ranked genes (i.e. ratio >1) for 
almost all α. The greatest excess occurred when α is between 0.01 and 1e-4. The highest 
ratio observed for the CLOZUK dataset is 1.531 (N=1%, α=10e-3) and for the ISC dataset is 
1.571 (N=10%, α=10e-4). 
 
Figure 4.6: Calculated ratios for the ISC (top panel) and CLOZUK (bottom panel) datasets 
of SNP-SNP interactions with a p-value below the significance level α (from 0.5 to 1e-4) in 
two groups: interactions involving genes most highly associated with schizophrenia and 
interactions involving genes that are least associated with the disease. 
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4.3.2.6  Networks 
As explained in section 4.2.8, it is possible that a proportion of disease-relevant SNPs (or 
genes) will contribute to multiple interactions. Two sets of the ranked interactions were 
plotted as network: 1% of SNP-SNP interactions involving genes most highly associated 
with the disease (highly ranked) and 1% of SNP- SNP interactions involving genes least 
associated with schizophrenia (lowest ranked). This particular threshold was used as it 
gives the clearest visualisation, however the same phenomenon is observed at different 
thresholds with a more complex graph structure. 
Each node represents a SNP (or a gene) and the link joining two SNPs (or genes) represents 
the existence of a pairwise interaction between them with p<0.01. 
This was done on the independent comparison for both the CLOZUK and the ISC datasets. 
 ISC  CLOZUK 
 
HRG LRG HRG LRG 
Number of interactions 
with p<0.01 
435 366 512 414 
Number of SNPs 427 218 478 354 
Number of genes 368 302 437 306 
Table 4.7: Number of interactions, number of SNPs and genes in each dataset after 
selecting 1% of SNP-SNP interactions involving genes most highly associated with the 
disease (highly ranked) with a p-value below 0.01 and 1% of SNP- SNP interactions 
involving genes least associated with schizophrenia (lowest ranked) with a p-value below 
0.01. (HRG: high ranked genes and LRG: low ranked genes) 
When plotting the network graphs (Figure 4.7 for CLOZUK and Figure 4.8 for ISC), different 
patterns can be observed. For the CLOZUK dataset in the network of interactions in high 
ranked genes (Figure 4.7A) for both the SNPs and the genes network, interactions are 
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clearly concentrated around a small number of hub SNPs (or genes). This is not observed 
in the networks of interactions in low ranked genes (Figure 4.7B). The same phenomenon 
was also observed in the ISC dataset (Figure 4.8). This indicates that a handful of SNPs are 
responsible for driving the interactions in the top of the distribution (Table 4.7). 
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Figure 4.7: Networks of SNPS and Genes interactions in the CLOZUK 
dataset. Interactions were ranked by gene-wide significances. 1% of 
interactions was selected with the highest ranking (A) (genes highly 
associated with schizophrenia) and with the lowest ranked interactions (B) 
(genes least associated). In both groups, interactions with p< 0.01 were 
selected to drawn the network. For interactions in high ranked genes, the 
network appears to present hubs both in SNPs and Genes networks (A).  
 
 
Figure 4.8: Networks of SNPS and Genes interactions in the ISC dataset. 
Interactions were ranked by gene-wide significances. 1% of interactions 
was selected with the highest ranking (A) (genes highly associated with 
schizophrenia) and with the lowest ranked interactions (B) (genes least 
associated). In both groups, interactions with p< 0.01 were selected to 
drawn the network. For interactions in high ranked genes, the network 
appears to present hubs both in SNPs and Genes networks (A). 
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The hubs were further examined to assess whether additional biological information could 
be derived from them. The top 5 hubs (the hubs with the highest degree) in each dataset 
were selected. The DAVID database (Sherman et al. 2007) was used to assess whether any 
biological process (GO term) was shared between genes connected to the same hub 
compared to other genes present in the network. This GO analysis looked for evidence 
supporting a link between the observed hubs and biological processes. In both datasets, 
no enrichment for GO term was detected.  
In order to assess whether the observed hub-effect was a statistical artefact, I investigated 
the relationship between the gene degree (number of link) in each network (Figure 4.7 and 
Figure 4.8) and the gene length. As showed by the correlation table (Table 4.8), there is no 
relationship between the gene length and the gene degree in the high ranked genes 
network. The opposite is observed for the lowest ranked genes network. 
Correlation between number gene 
degree and gene length 
ISC  CLOZUK 
HRG LRG HRG LRG 
Pearson 
correlation 
R 1.03e-2 0.513 0.0625 0.280 
P-value 0.843 < 2.2e-16 0.262 1.53e-6 
Spearman rank 
correlation 
R -5.27e-3 0.399 -4.72e-2 0.222 
P-value 0.919 1.27e-10 0. 3976 1.57e-4 
Table 4.8: Calculated correlation coefficients (Pearson and Spearman) between the 
number of gene degree and the gene length in the hub network for both the ISC and 
CLOZUK dataset. HRG=High Ranked Genes. LRG=Least Ranked Genes. 
Similarly, the relationship between the gene degree in the hub network and the number 
of SNPs per gene was investigated. The correlation table (Table 4.9) showed a strong 
relationship between the gene degree and the number of SNPs per gene in both high 
ranked genes and low ranked genes networks. 
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Correlation between number of gene 
degree and number of SNPs 
ISC  CLOZUK 
HRG LRG HRG LRG 
Pearson 
correlation 
R 0.479 0.784 0.458 0.622 
P-value < 2.2e-16 < 2.2e-16 < 2.2e-16 < 2.2e-16 
Spearman rank 
correlation 
R 0.599 0.608 0.435 0.408 
P-value < 2.2e-16 < 2.2e-16 < 2.2e-16 1.10e-13 
Table 4.9: Calculated correlation coefficients (Pearson and Spearman) between the 
number of gene degree and the number of SNPs per gene in the hub network for both the 
ISC and CLOZUK dataset. 
 
4.3.3  Overall assessment of the functional annotation 
SNP-SNP interactions with a p-value below 1x10-4 were further analysed using the DAVID 
database to investigate if biological processes were shared among them (Table 4.10). I 
compared the results obtained for the CLOZUK dataset with those for the ISC dataset. This 
purely descriptive analysis was performed both for the results obtained from the 
independent comparison (using different SNPs for both datasets) and for those from the 
common-SNP comparison. Due to lack of time, this analysis only aims to give a brief 
description of preliminary results that would need further investigation to be complete. 
Annotation category with a p-value equal or smaller than 0.05 was considered as 
potentially relevant (Sherman et al. 2007).  
 Independent analysis  Common-SNPs analysis 
 
ISC CLOZUK ISC CLOZUK 
Number of genes 502 600 1,036 1,102 
Number of genes used 
as background list 
2,080 2,418 2,791 2,791 
Table 4.10: Number of genes into the main and the background list for the analysis in 
David.  
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In the independent analysis, 14 GO-terms were identified as significant for the ISC dataset 
and 6 GO-terms for the CLOZUK dataset (Figure 4.9, top). No shared process between the 
two was found.  
In the common SNPs analyses, 7 GO-terms were found to be enriched in the ISC dataset 
and 5 in the CLOZUK dataset (Figure 4.9, bottom). One shared process was identified 
between the two dataset: GO:0007156 homophilic cell adhesion via plasma membrane 
adhesion molecules. Other similar functions are shared: transmembrane transport and 
calcium ion transmembrane transport.  
Taking into account multiple test correction (FDR rate), no GO terms was found to be 
significant in either analyses. 
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Figure 4.9: GO-terms analysis for the independent and same-SNPs comparison in both ISC 
and CLOZUK datasets. 
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4.4  Discussion 
4.4.1  Towards a better understanding of gene-gene interactions in schizophrenia 
A detailed study of genetic interactions was performed on two non-overlapping 
schizophrenia GWAS datasets. Analyses were first performed independently in each 
dataset; the SNPs used being different and specific to each dataset. To investigate whether 
results were sensitive to differences in the SNP content of the genotyping chips used in 
each study, and to make the analysis more directly comparable, the procedure was re-run 
after selecting for common variants present in both datasets. In every analysis, no 
interaction survived correction for multiple testing. This is unsurprising as the sample sizes 
are still insufficient to reliably detect individual interactions statistically. 
To investigate whether genetic information alone could be used to identify sets of genes 
enriched for interactions, SNP pair-wise interactions were calculated and ranked by the 
gene wide significance of the genes involved in each interaction. First the comparison of 
Spearman correlation coefficients between the interaction p-values and the gene-wide 
significance p-values revealed a weak relationship between the two in the independent 
analysis (for both CLOZUK and ISC datasets). However this was not the case for the 
common-SNPs analyses. 
The distribution of interaction p-values in high ranked genes (for which there was greatest 
gene-level evidence of main effects contributing to disease) was then compared to that in 
low ranked genes. Analysing samples independently (selection of SNPs being specific to 
each datasets), there was evidence for an enrichment of significant interactions amongst 
genes with the highest gene-level evidence of association when compared to interactions 
involving the least associated genes. The observed effect was stronger for the CLOZUK than 
the ISC dataset: this is probably due to an insufficient power to detect the effect in the 
smaller set of genes in the ISC dataset (the dataset being smaller). Furthermore, as 
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indicated by the ratio comparison the observed effect was the strongest when comparing 
the distribution of interaction p-values between the 1% of SNP-SNP interactions between 
SNPs in genes highly associated with schizophrenia with the 1% of SNP-SNP interactions 
between SNPs in genes least associated with the disease. This is the first consistent 
evidence that genes contributing to schizophrenia risk also interact.  
Investigating interactions with a p-value <0.01 in those groups, it was found that several 
SNPs acted as hubs for the interactions within the genes most highly associated with 
schizophrenia. When looking at the interactions within the other group (genes least 
associated with schizophrenia) no SNP hub was evident. Further assessment of the genes 
involved in the top five hubs did not reveal any shared biological process in the CLOZUK 
dataset.  
Potential statistical artefacts were investigated. The relationship between the degree of 
each gene (number of links) and the gene length was assessed: for the low ranked genes 
networks in both the ISC and CLOZUK datasets the correlation coefficients showed a stable 
relationship whereas the opposite was observed for the high ranked genes networks. As 
high ranked genes tend to be larger in size than low ranked genes, it does not appear to 
create a bias in the high ranked genes networks as no correlation is observed between the 
degree and the length of each gene. A second relationship was assessed between the 
degree of each gene and the number of SNPs per gene. For both the high ranked genes 
and the low ranked genes networks a strong correlation between the variables was 
observed. As this effect is present in every network it does not seem to play a role in the 
hub pattern observed. 
 
When performing the common-SNP comparison the previously detected enrichment 
effect of significant interactions within highly associated genes was no longer evident. One 
explanation for this would be that common SNPs between the CLOZUK and the ISC datasets 
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are contributing less to the interactions effects than the ones identified with the 
independent comparison. It is also possible that interaction effects are more sensitive to 
sample differences than main effects. Other factors could also explain this difference and 
will be detailed in the following section. 
To further investigate the observed effect, different rankings were performed on the 
interaction data. The ranking by the gene-wide significance calculated on the PGC2 dataset 
showed similar effect to those previously observed: enrichment was detected in both ISC 
and CLOZUK datasets in the independent analysis but not in the common-SNPs analysis. 
However when the ranking was done using the gene-wide significance from the other 
dataset (using ISC gene wide significance to rank CLOZUK interactions and vice versa), no 
effect was observed in both the independent and the common-SNPs analyses. Several 
factors could contribute to these observations. Firstly the sample size, the ISC dataset is 
significantly smaller: perhaps there is a lack of power to evaluate the gene-wide 
significance in this dataset. This would explain why when using PGC2 gene-wide 
significance to rank ISC interactions, a bigger enrichment of ‘significant’ interactions in high 
ranked genes is detected. However this does not explain why there is enrichment in ISC 
interactions ranked by ISC gene-wide significance. If it is simply power that is needed to 
identify gene-wide association, then using the CLOZUK gene-wide significance to rank ISC 
interactions should be better than ranking the same interactions by ISC gene-wide 
significance, which is not the case. Nevertheless, PGC2 dataset is closer in size to CLOZUK 
dataset than ISC dataset but the ranking by PGC2 seems to produce a stronger signal in the 
ISC dataset than in the CLOZUK dataset. Secondly the chip type, the CLOZUK dataset uses 
more recent and more similar genotyping chips than many of the PGC2 samples. In 
addition, the ISC dataset uses a mix of Affymetrix chips. Perhaps the chip quality influences 
the power to detect true effects and having to correct for multiple chips, this decreases 
their power to identify interactions. Thirdly the sample homogeneity, the CLOZUK dataset 
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is a more homogeneous sample with less population sub-structure than the ISC (or the 
PGC2) dataset. Perhaps by using the CLOZUK dataset, population-specific effects are picked 
up whereas the ISC (or the PGC2) dataset will pick up more generic effects. This could 
explain the similarity between ISC and PGC2 and their difference to CLOZUK. The disease 
biology, as cases in the CLOZUK dataset are treatment-resistant it may be that a large 
proportion of the interactions picked up are specific to treatment-resistance. Finally 
looking at gene-wide p-value between the three datasets, ISC and CLOZUK are more highly 
correlated with PGC2 than with each other. This would explain why ranking with PGC2 
gene-wide p-values gives more similar results than ranking ISC with CLOZUK gene-wide 
significance (and vice versa). Also it is worth noticing that the correlation between the two 
largest datasets (CLOZUK and PGC2) is moderate (R~0.3) indicating that gene-wide 
significance are still quite variable in samples of these sizes. 
 
Following those results, I further investigated if some of the interactions results could be 
driven by confounding factors present in GWAS data but not related to disease. In order to 
assess it, all the interactions were re-ranked using gene-wide p-values from others neuro-
psychiatric/-degenerative disorders. Regarding the independent comparison, the results of 
this cross-disorder analysis showed no evidence that the interaction results were driven by 
such confounds. Indeed no enrichment was detected when ranking interactions by gene-
wide significance from GWAS from genetically unrelated (as far as it is known) disorders. 
In addition, it was found that Bipolar Disorder gene-wide p-values could be used to identify 
genes enriched for schizophrenia-associated interactions in one dataset, which could be 
explained as Bipolar Disorder and Schizophrenia share genetic factors (Lichtenstein et al. 
2009) if it is a genuine effect. No replication was observed in CLOZUK, indicating that 
perhaps the effect is not genuine. When performing the cross-disorder investigation on 
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the common-SNPs comparison, no enrichment was observed in either the CLOZUK or the 
ISC datasets. 
 
Finally interactions with a p-value below 1x10-4 were further investigated in order to assess 
if biological processes were shared among them.  
The preliminary results from this descriptive analysis showed that some interesting 
biological processes (GO terms) involving synapses or ion transport are involved among 
‘significant’ interactions in both datasets. In the common-SNPs analysis some processes 
are common between CLOZUK and ISC. In addition DAVID does not take into account gene 
size or the number of semi-independent variants. The larger the gene, the more likely it is 
to have multiple semi-independent SNPs and the more SNPs, the more likely it is to find a 
‘significant’ interaction by chance. As brain genes tend to be larger, gene size can influence 
both probability of finding an interaction and the functional annotation. Further work 
would need to use an enrichment test that accounts for those differences. 
4.4.2  Detection and replication of results: challenges and conclusion 
The main challenge in a genetic interaction study has often been the detection of 
significant results (McCarthy et al. 2008). Indeed, very few genome-wide epistasis studies 
have discovered significant interactions (McCarthy et al. 2008). In this chapter, none of the 
individual interactions studied in the four analyses survived correction for multiple testing. 
Indeed, the sample sizes are still insufficient to detect individual interactions statistically. 
This indicates a lack of power and that individual interactions contributing to disease risk 
are likely to have extremely modest effect sizes. This problem could be overcome by using 
bigger sample size. For comparison, one of the first GWAS to detect a genome-wide 
significant main effect in schizophrenia required 3,322 cases and 3,587 controls (Purcell et 
al. 2009). For interactions, the sample size needed would be bigger (Wang and Zhao 2003). 
The sample size required to detect an interaction effect is inversely proportional to the 
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square of the effect size (Zuk et al. 2012): for N loci with similar effects, the sample size to 
detect N2 interactions scales with N4. 
Reducing the number of SNPs in the interaction analysis would also contribute to diminish 
the multiple testing burden and make the threshold for significance less stringent. 
However if the effect sizes of the interactions are lower than the size of the main effects 
then it will become extremely unlikely to detect such effects. In addition, it could be argued 
that by reducing the number of SNPs in the analysis, a increasing number of the 
interactions passing the multiple correction thresholds could be in fact false positives. For 
example, we can see a parallel with early candidate genes studies where most of the 
significant results obtained were in fact false positive. As a result a threshold of 5e−8 has 
become the significance standard in GWAS (International HapMap Consortium 2005). In 
this thesis, a stringent Bonferroni correction is applied and sets the significance threshold 
as 0.05 divided by the number of tests. As the number of interactions tested is substantial, 
the threshold is highly conservative: the cost of avoiding too many type I error can then 
result in a loss of power (Musani et al. 2007). Perhaps best practice should be that no 
matter of the number of variants used in an interaction analysis, an appropriate genome-
wide significance threshold should be used for pairwise interactions (Musani et al. 2007).  
In addition, to deal with population stratification, the analysis was done separately on the 
eight populations of the ISC dataset. Similarly the two chips of the CLOZUK data have been 
analysed independently and the results have then been combined for analysis. Perhaps 
true interactions have been lost in that process. 
Another challenge for gene-gene interaction studies is the replication of results (Hemani 
et al. 2014; Chu et al. 2014). In this chapter, some results are partially replicated. For 
example, when performing an independent comparison, when the SNPs are specific to 
each dataset, there is an excess of significant interactions within genes that related to 
schizophrenia: this effect is strongly observed in the CLOZUK dataset as well as the ISC 
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dataset. The difference of sample size in term of both number of cases and controls as well 
as number of SNPs between the CLOZUK and the ISC dataset might explain the difference. 
In addition as gene-wide p-values are quite variable between the datasets, the ranking of 
interactions is not stable: large samples are certainly needed to overcome this. 
Supposing that there are multiple reasonably distinct sets of biological pathways 
contributing to schizophrenia, it may be that one sample is (by chance) more enriched for 
individuals with perturbations of one set of pathways and the other sample enriched for a 
different set of pathways. Then the SNP/gene main effects and interactions within each 
dataset would be drawn from the same set of genes but there would be much less overlap 
between datasets. A bigger sample, similar to PGC2, would be needed to identify signals in 
both sets of pathways at the same time. In addition ranking by gene-wide p-values in this 
better powered dataset should reveal evidence for interactions in the smaller datasets.  
4.4.3  Summary of the chapter 
In this chapter, I investigated SNPs-SNPs interactions in two independent and non-
overlapping GWAS datasets. When performing the independent comparison (markers 
specific to each dataset), an enrichment of significant interactions within genes that are 
most highly associated with schizophrenia was detected. However that effect was not 
observed when using the common SNPs between the datasets. 
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Chapter 5 -  Interaction in GWAS datasets using data from 
protein-protein interactions 
5.1  Introduction 
5.1.1  Background 
Finding gene-gene interactions in human genetic data has proven to be a difficult task 
(Gilbert-Diamond and Moore 2011). As illustrated in section 4.2.5 of Chapter 4, many 
factors contribute to the explanation of a lack of success in interaction detection: low 
statistical power, severe multiple testing correction, small effect size, lack of large sample 
size (Moskvina et al. 2011). 
To help overcome such problems, the prioritisation of the SNPs used in the interaction 
analysis is a key factor (Moskvina et al. 2011). In Chapter 4, SNPs within genes were 
selected using LD pruning. In this chapter I investigate whether functional information such 
as protein-protein interactions can be used to prioritise genes. 
Protein-protein interactions (PPI) are physical contacts between proteins that allow the 
formation of more complex functional units. As protein rarely acts alone, such units are 
particularly important as many molecular processes depend on it. This explains the growing 
interest in the study of such units: for example one study (Pawson and Nash 2000) have 
shown that the specificity in signal transduction relies on PPI. 
As detailed in section 1.3.3 of Chapter 1, large-scale studies of PPI have allowed the 
identification of thousands interactions as well as the creation of several public PPI 
databases such as BIND (Bader et al. 2003), HPRD (Mishra et al. 2006) or Intact (Kerrien et 
al. 2007).  
Furthermore some efforts have been made to obtain comprehensive screens (which 
investigate all potential interactions within a particular set of proteins) with PPI thoroughly 
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verified. However while comprehensive screens are more likely to contain good quality PPI, 
they are still far from complete and a large proportion of all potential interactions have yet 
to be investigated. 
Nevertheless, newly discovered PPI are mostly found in small studies rather than in large 
comprehensive screenings. Furthermore their number keeps increasing exponentially with 
the progress of the technologies allowing their detection. As a result, the majority of newly 
discovered PPI will be available mostly in the literature, which renders the task of extracting 
all that information very difficult. 
5.1.2  Aim of the chapter 
The aim of the chapter is to investigate the relationship between biological interactions 
such as PPI and statistical interactions. PPI from both databases and literature curation will 
be used to assess the relationship.  
The first part of the chapter reviews three text-mining tools extracting PPI from abstracts 
and compare their performances. The best tool was then used to identify a set of PPIs 
through analysis of PubMed abstracts. 
The second part of the chapter will assess whether significant SNPxSNP interactions are 
enriched within sets of PPI from different source. 
In this chapter, screen PPI will refer to PPI discovered through high throughput screens 
(e.g. yeast two hybrid assays). Literature PPI will refer to PPI discovered through the 
analysis and curation of the literature (i.e. the results of numerous small-scale interaction 
studies), using text-mining tools for example. 
5.2  Materials and Methods 
5.2.1  GWAS data 
For this analysis, the CLOZUK dataset was used (Hamshere et al. 2013). It consists of a total 
of 5,200 individuals with schizophrenia and 5,987 healthy subjects from 8 different 
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populations. The data, including the quality control steps applied to it, was described in 
Chapter 2. 
The CLOZUK dataset was preferred to the ISC dataset (International Schizophrenia 
Consortium 2008) due to its larger sample size: higher number of cases and controls. A 
meta-analysis of both datasets would have also solved the sample-size issue but the 
number of common variants between the two datasets was deemed too low to proceed. 
5.2.2  Text Mining 
5.2.2.1  Background 
As discussed in Chapter 1, advances in Natural Language Processing (NLP) techniques have 
allowed the development of tools for extracting information such as PPIs from text. 
After reviewing the available literature on the different PPI extraction tools, three were 
selected for further comparison (Table 5.1): ODIN (Rinaldi et al. 2014), PPIInterFinder (Raja 
et al. 2013) and @Note (Lourenço et al. 2009). The selection criteria for this review 
included the availability of the tools as well as the described performance. 
Name Type Limitations Strengths 
PPIInterFinder Web based 
Limited number of abstracts to 
be processed (10) 
Three different options to 
upload the input 
ODIN Web based 
Not fully publicly available for 
personal use 
Processed on the entire 
PubMed 
@note2 
open 
source 
Limited number of abstracts to 
be processed (100) 
Very user friendly 
Table 5.1: Limitations and strengths of the different PPI extraction tools 
ODIN is a web service that allows the extraction of PPI from abstracts. It uses the 
annotation standard BioC (Comeau et al. 2013). BioC is a data format based on the XML 
language: it facilitates the data exchange for systems that process biological texts. In 
addition ODIN has been presented at the Bio Creative challenge II.5 (Krallinger et al. 2011), 
where the results proved it to be an efficient and competitive tool. Its high ranking (best 
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results for the detection of protein-protein interactions) and its availability (not every tool 
participating to the challenges were public available) made it a strong candidate for the 
analysis.  
PPIInterFinder is a web-based tool that extracts human PPIs from abstracts of the 
biomedical literature. This tool uses the co-occurrence of protein names combined with a 
search for relational keyword in order to identify PPI candidate (Raja et al. 2013). The 
upload was limited to 10 abstracts at one time, making it quite hard to use for a large-scale 
analysis. 
@Note is a platform for Biomedical Text Mining that processes abstracts as well as full texts 
and retrieves PPI information within them. The software can be easily downloaded and has 
a very user-friendly interface (Lourenço et al. 2009). However the analysis was limited by 
an upload of 100 abstracts at one time. 
5.2.2.2  Corpora 
In order to evaluate the different text-mining tools and to assess their performance, each 
tool was tested on two selected corpora. The first corpus consisted of a collection of 100 
abstracts, created by a simple query in PubMed using the following Mesh Terms: protein-
protein interactions. Every abstract was manually checked to insure that the corpus 
contained a sufficient number of PPI. The second corpus was a sample of 100 abstracts 
randomly selected from the ACT corpus used in a well-known text mining event: the 
BioCreative Challenge (Krallinger et al. 2011). 
5.2.2.3  Indicators for performance assessment 
The approach used here consisted of testing each PPI extraction tool against the two 
corpora defined above. Three main indicators are commonly used to evaluate the 
performance of text mining tools: the recall, the precision and the F-measure. Those 
indicators are defined using the number of correct interactions detected (true positives 
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TP), the number of missed interactions (false negatives FN), the number of false 
interactions detected (False positives FP). 
The recall is the true positive rate or sensitivity: it measures the true positives that are 
identified and takes into account the number of those missed. It is defined as the following: 
𝑟𝑒𝑐𝑎𝑙𝑙 =
𝑇𝑃
𝑇𝑃 + 𝐹𝑁
 
The precision sometimes known as positive predictive value measures the number of 
correctly retrieved PPI by a method. It is defined as the following: 
𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 =
𝑇𝑃
𝑇𝑃 + 𝐹𝑃
 
It has been showed that these two measures are often negatively correlated (Rebholz-
Schuhmann et al. 2012): if the precision is increased, the recall measure can decreased. 
The best tool is the one that manage the best balance between those two measures: the 
F-measure. The F-measure is the harmonic mean of precision and recall and provides a 
single indicator: 
𝐹 =
2 × 𝑟𝑒𝑐𝑎𝑙𝑙 × 𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛
𝑟𝑒𝑐𝑎𝑙𝑙 + 𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛
 
5.2.3  Protein-protein interaction data 
5.2.3.1  Background 
Finding PPI has been an important challenge in the last decade to identify complex 
molecular mechanisms involved in a cell. As a result, the identification of thousands 
interactions has enabled the creation of numerous resources collecting the data together 
such as PPI databases as defined in Chapter 1, section 1.3.3. In addition, comprehensive 
screens of PPI have allowed the emergence of good quality and thoroughly verified PPI 
resource.  
However both types of resource present some limitations and challenges to overcome as 
seen in Chapter 1, section 1.3.3. For example comprehensive screens are highly dependent 
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on the number of proteins covered by the screen: in particular they might not cover 
synaptic PPI. 
For those reasons, I chose to use PPI issued from both resources: data from the Human 
Interactome Project (Rolland et al. 2014), a comprehensive screen of PPI, and data from 
two databases: the String database (Szklarczyk et al. 2015) and the synaptic set of PPI 
within the Intact database (Orchard et al. 2014). Differences between the sets will be 
briefly assessed in this chapter and I will investigate whether those sets are enriched in 
statistical interactions. 
5.2.3.2  Human Interactome Project 
The Human Interactome Project (HIP) aims to build a reference map of the human PPI 
network by describing all of the physical interactions between each protein. The approach 
consists of using yeast two-hybrid assay (Y2H) experiments in Human Embryonic Kidney 
cells (HEK293) to obtain high quality interactions. As HEK293 is a cell line derived from 
kidney cells, it is indeed possible that this dataset contains tissue specific PPIs but it will 
also contains non-tissue specific interactions that are of interest. In addition, PPIs have 
rarely been identified in the context of distinct cell types but a few studies are aiming to 
correct this (Yeger-Lotem and Sharan 2015).  
Five datasets of PPI are available on the HIP website which were used to form two sets of 
PPI. 
The two proteome-scale efforts HI-I-05 (Rual et al. 2005) and HI-II14  (Rolland et al. 2014) 
were grouped with two other maps containing high quality interactions identified during 
the development of the protocol: Venkatesan-09 (Venkatesan et al. 2009) and Yu-11 (Yu 
et al. 2011). Hi-I-05 screened a space containing over 7,000 genes and identified over 2,700 
binary PPI of high quality. HI-II-14 generated over 14,000 PPI. Venkatesan-09 contains over 
200 high-quality Y2H PPI and Yu-11 over 1,200 interactions. 
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The second set of PPI drawn from the HIP consisted of PPI obtained by extraction of 
information from known PPI databases such as BIND, BioGrid or DIP: Lit-BM-13 (Rolland et 
al. 2014). Out of those preliminary results, HIP selected only the PPI that were supported 
by at least two pieces of evidence from the literature (Rolland et al. 2014). 
To conclude, in the following analysis, two sets of PPI were derived using the HIP data: one 
supported experimentally and the other one supported by the literature. 
5.2.3.3  Intact Database 
The Intact database (Orchard et al. 2014) is an open source database containing interaction 
data curated from the literature and also from direct depositions. Out of the 
computationally maintained datasets of the database, one consisted of PPI with proteins 
known to have a role in the pre-synapse. This set of PPI was selected for the analysis. 
5.2.3.4  String Database 
The String Database (Szklarczyk et al. 2015) contains PPI obtained from three different 
sources: experimentally obtained PPI (drawn from the following databases: BIND, DIP, 
GRID, HPRD, IntAct, MINT, and PID), computationally predicted PPI and PPI extracted from 
the literature by a co-occurrence method. Two large sets of interactions were drawn from 
the database: One containing PPI experimentally obtained and the other of PPI extracted 
from the literature. Predicted PPI were excluded from this study as PPIs prediction tools 
are not sufficiently precise: many datasets are highly skewed containing many non-
interacting PPIs (Browne et al. 2010).  
5.2.4  Interaction analysis 
5.2.4.1  Workflow 
Figure 5.1 represents the workflow of the interaction analysis performed. Each step will be 
further detailed in the section below. 
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5.2.4.2  Gene Selection and PPI sets 
Four gene sets were selected using the different sets of PPI previously detailed in this 
chapter, section 5.2.3. 
The first one, SET1, contained genes involved within the PPI obtained from text-mining 
using the results obtained by the best text mining tool. 
Two sets of genes were drawn from the Human Interactome Project: one from the set 
generated through high throughput screening of PPIs (SET2A) and the set curated from the 
literature (SET2B). The PPIs from the two groups were combined, forming the SET 2. Using 
SET 2 set of interactions, it was possible to compare the enrichment for the same 
interactions in the subset SET 2A and the subset SET 2B. In addition, SET 2A was analysed 
on his own in order to assess whether enrichment could be observed within that good 
quality dataset only. 
The third set of genes, SET 3, consists of the PPI drawn from the synaptic dataset of the 
Intact database. 
The last set of genes, SET 4, was drawn from the String database, which contains a very 
high number of interactions: PPI from screening origin (SET 4A) and PPI extracted from the 
literature (SET 4B). As for the second set of genes, the analysis was carried out after joining 
the two sets for comparison. 
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Figure 5.1:Workflow of the analysis. PPI data and CLOZUK data are merged in order to select the genes common to both.  
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5.2.4.3  SNPs selection and clumping 
Firstly, only SNPs inside chosen genes were kept. The analysis focussed on autosomal 
chromosomes: all variants on X and Y chromosomes were removed as a separate analysis 
of male and female would have been needed resulting in smaller sample size and loss of 
power for detection. In addition, all the insertions and deletions were excluded from the 
analysis. The same clumping procedure described in Chapter 3 and 4 was used to restrict 
the number of SNPs using linkage-disequilibrium pruning. Only the most highly associated 
SNPs were kept using the option –clump in PLINK (Purcell et al. 2007). The following 
parameters were chosen: a window of 2,000 kb and r2 of 0.1 and p1 threshold of 0.01. 
When further investigation was needed, different p1 thresholds were tested (p1=0.05 and 
p1=0.1) in order to increase the number of SNPs used in the analysis. By increasing the 
number of variants used, it was then possible to investigate how stable the result was. 
5.2.4.4  Pair-wise SNP interaction 
As explained in detail in section 3.2.3 of Chapter 3 and section 4.2.5 of Chapter 4, 
interactions between all the possible pairs of clumped SNPs were calculated using PLINK 
1.9 (Purcell et al. 2007; Chang et al. 2015). As argued in section 4.2.3.3 of Chapter 4, the 
results obtained from the different chips were combined by means of a meta-analysis using 
the software METAL (Willer et al. 2010). 
 
5.2.4.5  Analysis of the results 
The analysis of the results relied onto the calculation of every possible pair of interactions 
between the clumped SNPs within genes previously identified in section 5.2.4.2.  
It also relied onto the comparison between the distribution of SNP interaction p-values for 
gene pairs linked to PPIs and the distribution of SNP interaction p-values for gene-pairs not 
linked by PPIs within the same set of genes. To assess if any enrichment of statistical 
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interactions could be detected, a Mann Whitney Wilcoxon rank test was used to compare 
the interactions in genes linked to PPI with the interactions in genes not involved with PPI. 
Then, a chi-square test was used to evaluate if there was an excess of genetic interactions 
with a p-value below two thresholds (p≤0.05 and p≤0.01) in interactions linked to PPIs 
compared to interactions not linked by PPIs within the same set of genes. When the count 
of interactions below the given threshold did not qualify for a chi-square test, Fisher’s exact 
test was used. 
 
5.3  Results 
5.3.1  Comparison of the three text-mining tools 
The three text-mining tools identified in section 5.2.2: ODIN, PPIInterFinder and @Note 
were tested against the two corpora described in section 5.2.2.2. 
The first corpus tested was the 100 abstracts sampled from the ACT corpus. @Note 
performed best in term of recall with a score of 0.92. However when looking at the 
precision, ODIN performed better with a score of 0.672. Taking into account the F-Score 
(measure that combines precision and recall indicators), ODIN obtains the higher score 
with a F-measure of 0.754 (Figure 5.2). 
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Figure 5.2: Result of the three tests performed (Recall, Precision and F-score) using the 
three text mining tools (ODIN, PPIInterFinder and @Note) against 100 abstracts randomly 
selected from the ACT corpus. 
 
The second corpus was a collection of abstract from PubMed, carefully selected using 
Mesh Terms. As in the previous test, @Note performed the best for the recall with a score 
of 0.915 but a lower score for precision. PPIInterFinder obtained the best precision score 
with a score of 0.667. However, ODIN with a F-measure of 0.679 obtains the best overall 
score (Figure 5.3). The F-measure is a balance between the recall and precision scores: it 
was chosen as the main indicator of performance for each tool. Having the highest F-
measure score, ODIN was identified as the best text-mining tool. 
In 2015, ODIN was run across all PubMed in the search for PPI. ODIN ranks the interactions 
it finds, using a scoring system to assess the likelihood of each interaction being a true PPI 
(Rinaldi et al. 2012). The calculated score is based on a machine learning process that can 
select interesting articles based on the previously classified articles (Rinaldi et al. 2012). 
Only interactions with a confidence score > 100 were kept for further analysis in order to 
select highly ranked interactions only (Rinaldi et al. 2012). 
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Figure 5.3: Result of the three tests performed (Recall, Precision and F-score) using the 
three text mining tools (ODIN, PPIInterFinder and @Note) against 100 abstracts selected 
from PubMed using MeshTerms. 
 
5.3.2  Summary of the different PPI sets used 
PPI Set Description 
Number of 
gene pairs 
Number of genes 
SET 1 
PPI extracted from the literature by 
the text mining tool ODIN 
21,525 4,001 
SET 2A 
Screen PPI from the Human 
Interaction Project 
15,254 4,480 
SET 2B 
Literature PPI from the Human 
Interactome Project 
10,183 5,295 
SET 3 
Synaptic PPI from the Intact 
Database 
3,453 1,720 
SET 4A Screen PPI from the String database 2,511,242 14,392 
SET 4B 
Literature extracted PPI from the 
String database 
5,744,559 16,137 
Table 5.2: Description of the different PPI sets analysed: number of gene pairs and number 
of genes 
Table 5.2 details the number of gene pairs and the number of genes involved in each PPI 
set or subset. As outlined in section 5.2.4.1 and showed by Figure 5.1, each PPI set was 
analysed independently. Both SET 2 and SET 4 contain PPI from screening origin as well as 
PPI extracted from the literature for comparison purpose between two sources of PPI. The 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
ODIN PPIInterFinder @Note
Sc
o
re
s
Text-mining tools tested
Recall
Precision
F-Score
Indicators:
 128 
subset SET 2A was also analysed separately in order to assess interactions in a high quality 
PPI dataset. The same clumping parameters were used for each set. 
Table 5.3 describes the different samples with the number of genes in each set as well as 
the number of SNPs used for the interaction analysis. 
PPI Set Description 
Number 
of Genes 
Number of SNPs 
prior to 
Clumping 
Number of SNPs 
after Clumping 
(p1=0.01) 
SET 1 
PPI extracted from the literature by 
the text mining tool ODIN 
4,001 398,134 865 
SET 2 
PPI from the Human Interaction 
Project 
Subset A: Screen interactions 
Subset B: extracted from literature 
7,879 775,445 1,583 
SET 2A 
Screen PPI from the Human 
Interaction Project 
4,480 357,087 830 
SET 3 
Synaptic PPI from the Intact 
Database 
1,720 211,503 452 
SET 4 
PPI from the String database 
Subset A: Screen interactions 
Subset B: extracted from literature 
16,192 1,570,015 2,849 
Table 5.3: Description of the different PPI sets analysed: number of genes, number of SNPs 
before and after clumping. 
 
5.3.3  Assessment of the enrichment of statistical interactions within PPI sets 
A Mann Whitney Wilcoxon rank test was used to compare the distribution of genetic 
interaction p-values for gene pairs linked by PPIs with the distribution of p-values for 
interactions within gene-pairs not linked by PPIs within the same set of genes. This test 
assessed if there was any enrichment of statistical interactions within gene pairs linked by 
PPIs.  
The results using the clumping parameter p1=0.01 (Figure 5.4) show that enrichment was 
only detected within the SET 3: the synaptic PPI from the Intact database: p=0.00031 
(Bonferroni threshold p=0.0071). 
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Figure 5.4: Ranking test for the enrichment of statistics interactions with low p-values 
performed on the different sets of PPI. The colour for each set corresponds to the ones in 
Figure 1.1. The black bar indicates the Bonferroni threshold (p=0.0071). Only SET 3 shows 
enrichment. 
 
In addition a chi-square test was used to see if an enrichment of interactions below the 
thresholds (p ≤ 0.05 and p ≤ 0.01) could be detected (Figure 5.5). When looking at 
interactions with p-values under the 0.05 threshold, only the synaptic PPI set (SET 3) shows 
an enrichment (p=0.0011, Figure 1.5A). However when performing the same test using a 
different threshold (p≤0.01, Figure 1.5B) no enrichment is detected in any SET of PPI. 
A 
0
0.5
1
1.5
2
2.5
3
3.5
4
SET 1 SET 2A
(SET2)
SET 2B
(SET2)
SET 2A SET 3 SET 4A
(SET4)
SET 4B
(SET4)
Te
st
 p
-v
al
u
e 
(-
lo
g1
0(
p
-v
al
u
e)
)
PPI sets
*
 130 
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Figure 5.5: Chi-square test results for each set tested when selecting interactions with p-
values below 0.05 (A) and below 0.01(B). The colour for each set corresponds to the ones 
in Figure 1.1. The black bar indicates the Bonferroni threshold (p=0.0071). Only SET 3 
shows enrichment when looking at interactions with p-values below 0.05 (A).  
 
Following the detection of enrichment of statistical interactions with low p-values within 
SET 3, further analysis were performed away. The number of SNPs used in the analysis (452 
SNPs) was quite small: the clumping parameters were altered in order to increase this 
number (p1=0.01 and p1=0.05, Table 5.4) and the same analysis was performed.  
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 Number of SNPs in SET 3 
Prior to clumping 211,503 
After Clumping (p1=0.01) 452 
After Clumping (p1=0.05) 1,439 
After Clumping (p1=0.1) 2,435 
Table 5.4: Number of SNPs in SET 3 prior to clumping and after clumping using three 
different parameters: p1=0.01, p1=0.05 and p1=0.1. 
 
Figure 5.6 shows the results of the Mann Whitney Wilcoxon rank test: the only enrichment 
detected remains the one observed initially. By increasing the number of SNPs in the 
analysis, no additional enrichment of interactions is detected in SET 3. 
 
 
Figure 5.6: Ranking test for the enrichment of statistics interactions with low p-values 
performed on SET 3 using three different clumping parameters (p1=0.01, p1=0.05 and 
p1=0.1). . The black bar indicates the Bonferroni threshold (p=0.017). The same 
enrichment detected is the same as previously observed in Figure 5.4. No additional 
enrichment is observed by increasing the number of SNPs into the analysis. 
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5.4  Discussion 
5.4.1  Perspective on the extraction of PPI by text-mining tools 
Three different tools were compared to assess the feasibility of PPI extraction among a 
collection of abstracts. Three tools were selected for further comparison: ODIN 
PPIInterFinder and @Note. The F-score being a balance between the precision and the 
recall, it was the indicator of choice to compare the tool’s performance. Out of the three 
tools, ODIN was the one that performed the best, achieving a F-score of 0.754 and 0.679 
on the two corpora tested. In addition, ODIN was able to process the whole of PubMed, 
making it a superior candidate for this analysis. 
Despite those promising results, PPI detection from abstracts is not extremely precise and 
reliable: there are still place for improvement for PPI-extraction tools. Perfect PPI detection 
from text is not yet possible but current tools are likely to have an impact on simplifying 
the process of PPI article selection (Krallinger et al. 2011). One of the main challenges to 
be face by PPI-extraction tools is the recognition and extraction of novel interaction from 
text (Krallinger et al. 2011). Furthermore there is also an interest in being able to distinguish 
direct and non-direct interaction usually involving contact between more than two 
proteins (Krallinger et al. 2011). The current development of machine learning techniques 
such as graph kernel approaches (Airola et al. 2008) or support vector machines methods 
(Yang et al. 2010) should help to tackle those issues. Machine learning methods have the 
advantage of deriving information from their training dataset (Krallinger et al. 2011), 
making it interesting candidates for PPI-extraction tools. 
However with the rise of projects such as the Human Interactome Project (Rolland et al. 
2014) the potential interaction space is better covered by high throughput screens. As a 
result, in the future there may well be less need for tools that collect PPI information from 
small-scale studies.  
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5.4.2  Perspective on PPI and statistical interactions 
To investigate whether PPI could help to identify sets of genes enriched in significant 
statistical interactions, I selected PPI sets from four different sources. The first subset was 
generated from ODIN’s results: PPI extracted from abstracts of PubMed. Two subsets of 
PPI were drawn from The Human Interactome Project: one from comprehensive pairwise 
screens and the second from PPI supported by the literature. From the Intact database a 
third set was created that specifically contained synaptic PPI data. The final set was formed 
of PPI from the String database with two subsets: PPI supported by Y2H experiments and 
PPI extracted from the literature. 
Using a ranking test, I tested for an enrichment of significant SNPxSNP interactions within 
sets of genes linked to PPIs. The PPI set from the Intact database, containing the synaptic 
PPI was the only significant result that was detected. Using a chi-square test, this 
enrichment was further investigated in order to assess whether interactions with a p-
values below 0.05 and 0.01 were enriched in each set of PPI. In the first case, an enrichment 
was detected in the synaptic set of PPI (SET 3). However when examining interactions with 
p-values below 0.01, the effect disappear, probably due to the small number of 
interactions selected that results in a loss of power.   
Furthermore different clumping parameters were used on the synaptic PPI set in order to 
increase the number of variants used in the analysis. No enrichment was detected when 
performing the same analysis with a higher number of variants.  
The genes involved in this PPI set (SET 3, synaptic dataset from the Intact database) are 
brain-related genes linked with synaptic functionalities. As schizophrenia is a psychiatric 
disorder it is very likely that such genes would be relevant for the disease and hence be 
enriched with significant interactions.  
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However the analysis compared SNP-SNP interaction p-values for gene pairs linked by PPIs 
to gene pairs not linked by PPIs within the same set of synaptic genes. As a result the 
analysis controls for a general enrichment of significant interactions between synaptic 
genes. The result found here is a potentially interesting finding that would need to be 
followed-up in a larger sample. A bigger dataset composed of the ISC and CLOZUK datasets 
combined could have been used to that extend. The sample size issue would have been 
tackled but I choose not to use it: the number of common variants between the two 
datasets was low and I would have had to exclude many PPI pairs from my analysis. 
Imputing the ISC dataset might have solved that issue but it was not available at the time 
of the analysis. 
Furthermore many studies showed a link between schizophrenia and synaptic genes 
(Glessner et al. 2010; Fromer et al. 2014). For example the gene NRXN1 that encodes a 
membrane protein involved in the formation of synaptic contacts, has been found to 
increase the risk in schizophrenia (Kirov, Rujescu, et al. 2009). In addition schizophrenia 
was linked with de novo mutations in the ARC (activity-regulated cytoskeleton-associated 
protein) and NMRAM (N-methyl-D-aspartate receptor) complexes that are involved in 
synaptic functions (Kirov et al. 2012). These studies’ findings reinforce the interest in the 
main finding of this chapter: the link between PPI from a synaptic dataset with the 
interactions analysis on a schizophrenia dataset. 
 
5.4.3  Summary of the chapter 
In this chapter, I investigated whether PPI could be used in order to detect significant 
interactions. After reviewing the literature, I compared three text-mining tools able to 
extract PPI from abstracts. The best tool was selected to identify a set of PPIs through 
analysis of PubMed abstracts. In addition, I also used other PPI sets from available 
databases and high throughput screens in order to assess whether significant SNPxSNP 
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interactions were enriched within those sets of PPI. Only the set of synaptic PPI from the 
Intact database presented an enrichment of significant interactions. This result is 
potentially interesting given that several studies showed a link between schizophrenia and 
synaptic genes (Fromer et al. 2014) and it needs to be follow-up in a larger sample. 
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Chapter 6 -  Discussion 
6.1  Summary and implication of results 
6.1.1  Taking into account the population structure in an interaction analysis 
Regression-based methods are the most frequently used approach in an interaction 
analysis and show the effect of predictor variables on the disease. In a case-control 
analysis, this method consists of testing the interaction term only using a logistic regression 
model as described in Chapter 1. However, interaction analysis studies do not often 
account for population structure. In Chapter 3, I explored three different ways to account 
for population structure in an interaction analysis. The three models were tested on the 
same GWAS dataset where cases and controls belonged to 8 different sub-populations. 
This allowed the inclusion of the sub-population information as a covariate in the 
interaction analysis. When dealing with covariates, the most broadly used method consists 
of adding the covariates as extra terms into the equation. Following recommendations by 
Yzerbyt et al. (2004), the second method takes into account the possible effect between 
the covariates and each marker by adding interaction terms between covariates and 
markers into the equation. Indeed adding the extra interaction terms between covariates 
and markers allows to control for the effect those covariates could have on the main effect 
(Yzerbyt et al. 2004; Keller 2014). Finally in the last tested model, interactions were 
calculated independently for each sub-populations and a meta-analysis was used to 
combine the results. The methods produced similar results overall, indicated by a good 
correlation between them. The first two methods were found to have extremely similar 
result. Therefore while interactions between markers and covariates are possible, they do 
not seem to play a big role in practice and the bias mentioned by (Yzerbyt et al. 2004) is 
not observed in the analysed dataset. To definitely prove this hypothesis a large-scale 
simulation study is needed. It was interesting to assess the differences between these two 
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methods and the one using the meta-analysis. The produced results of the meta-analytic 
method were slightly more divergent from the other two methods but there was no 
evidence for any systematic differences. Such differences are likely due to increased 
variance for each individual study when analysing studies separately and results in a loss of 
power. 
In terms of running time and memory efficiency of the different methods, the meta-
analytic approach outperformed the other two, making it the easiest and fastest method 
to carry out interaction analyses for thousands of SNPs. 
Further comparisons between the three methods focused on the lower tails of the p-value 
distributions. The method adding covariates and the one suggested by (Yzerbyt et al. 2004) 
that adds covariates and the interaction terms between covariates and each marker 
showed good correlation. However, when comparing those two methods with the meta-
analytic approach some differences were observed. In some cases the meta-analytic 
method was able to identify interactions with reasonably low p-values while the other two 
methods were not. The opposite was also observed. Upon investigation of the direction of 
effect, the meta-analytic approach differs most from the other methods when the 
direction of effect is identical in only four or five out of 8 studies. In addition it is possible 
that the meta-analytic approach over-estimate the results, which could explain the 
differences observed. Indeed this method does not include the main effects: only the 
interaction terms are meta-analysed possibly resulting in the interaction term capturing 
some of the main SNP effects. Further investigation of this issue should include the 
application of a multivariate meta-analysis such as the one described in Van Houwelingen 
et al. (2002), to see if it improves the results. Finally it is also possible that a loss of power 
of detection is observed in the other two methods. By adding extra terms in the model the 
number of degree of freedom is increased and can cost precision in the estimation of 
parameters. 
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6.1.2  Identifying sets of genes enriches for SNPs-SNPs interactions 
6.1.2.1  Approach based on genetic information 
In Chapter 4 I aimed to determine whether genetic information could be used to identify 
set of genes enriched for disease-relevant statistical interactions. In order to investigate 
this, I assessed interactions in two independent and non-overlapping GWAS datasets. The 
first analysis was an independent one where the SNPs were specific to each dataset. The 
second analysis was performed after selecting the SNPs common to both datasets. LD 
clumping was performed in each dataset to reduce the number of variants in the analysis 
in order to avoid collinearity problems and diminish the multiple testing burden. All pair-
wise SNP interactions were then calculated.  
As expected, in every analysis, no interaction survived correction for multiple testing: the 
sample sizes were not large enough to detect individual statistical interactions. Interactions 
were ranked using gene-wide significance p-values. Spearman ranking correlation was 
calculated between the interactions p-values and the gene-wide significance. It showed a 
small positive relationship between the two in the independent analysis, meaning that 
there is slightly greater evidence for SNP interactions between genes more highly 
associated with schizophrenia. This was not observed for the common-SNPs analysis.  
I then investigated whether an enrichment for more significant interaction p-values was 
observed among the subset of genes that were most highly associated with schizophrenia 
when compared to genes that were least associated. 
When performing the independent comparison between the two datasets with variants 
specifically selected in each one, there was evidence for enrichment of more highly 
associated interactions amongst genes that are most highly associated with schizophrenia 
compared to interactions in the least associated genes. The observed effect was strongest 
for the CLOZUK dataset, which is the bigger dataset. In addition, the effect was the 
strongest when comparing the ranked distribution of SNP-SNP interactions p-values 
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between the 1% of SNP-SNP interactions involving genes most highly associated with the 
disease and the 1% of SNP-SNP interactions involving genes that are least associated with 
schizophrenia (i.e. after ranking interactions by gene main-effects). 
However, when performing the common SNP comparison, no evidence for an enrichment 
of associated interactions was observed. When ranking by the gene-wide significance of 
the PGC2 dataset, the same non-enrichment pattern was observed. 
Looking at correlation between gene-wide significance p-values ISC and CLOZUK are better 
correlated with PGC2 than with each other: this would explain why ranking CLOZUK SNP-
SNP interactions with PGC2 gene-wide p-values gives more similar results than ranking 
CLOZUK with ISC gene-wide significance (and vice versa). Also the best observed 
correlation between CLOZUK and PGC 2 (the two largest datasets R~0.3) was not high: this 
indicates that the gene-wide significances are quite variable from one samples to another. 
As a result, the ranking per gene-wide significance might not be extremely stable. 
On further investigating interactions with a p-value <0.01 in the independent analysis, it 
was found that several SNPs acted as hubs in the network formed by genetic interactions 
between high ranked genes. Potential statistical artefacts were explored (relationship 
between gene degree and length of gene and between gene degree and number of SNPs). 
Similar effect is observed when comparing gene degree and number of SNPs per genes. 
When comparing gene degree and gene length, good correlation was found between the 
two variables for the network involving the lowest ranked genes (network without the hub 
pattern). One explanation for this observation could be linked to the largest size of brain 
genes: as it is possible that brain genes are highly associated with schizophrenia it is unlikely 
that there are found into the lowest ranking genes network. As a result, smaller genes are 
probably involved in the lowest ranking genes network thus creating a bias.  
Several factors could further explain the observed differences between the two datasets. 
Cases in the CLOZUK dataset were treatment-resistant which was not true for the ISC 
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dataset where we would only expect roughly one third to be treatment resistant. This could 
lead to have slightly different genes associated with each phenotype and perhaps the 
interactions picked up could be specific to treatment-resistance. Furthermore the 
population of the two datasets is different: British population in the CLOZUK dataset and a 
mix of 8 different populations (British, Swedish and Bulgarian) in the ISC dataset. As a 
result, if interactions are enriched between the most associated genes and if a different 
set of genes is driving the association signal in each sample (due to phenotypic differences 
or variability of the population between the two datasets), interactions seen in one dataset 
might not be seen in the other. In addition, the presence of noise due to the small sample 
size could also explain the failure to identify enrichment within schizophrenia associated 
genes. Different genotyping chips were used in the two studies and the CLOZUK dataset 
uses more recent chips. Perhaps the chip quality influences the detection of true effects 
and having to correct for multiple chips, the power of detection is lowered. 
The results of the cross-disorder analysis within the independent comparison did not 
provide evidence that the observed effect was driven by confound inherent in GWAS data 
but unrelated to disease. Furthermore it is interesting to note that interactions within 
bipolar disorder genes are enriched for significant interactions using the ISC dataset. 
However this did not replicated in the CLOZUK dataset. 
 
The final step of this chapter was the investigation of interactions with a p-value below 
0.01. This consisted of a preliminary analysis of the biological functions shared among such 
interactions after selecting terms with p<0.05 which shows a small degree of enrichment. 
Some GO terms were shared between CLOZUK and ISC for the common-SNP analysis. 
However none of the terms identified passed multiple correction testing. 
It will need further work in order to see if biological process could help to identify groups 
of genes between which an enrichment of significant interactions is observed.  
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6.1.2.2  Approach based on the use of protein-protein interactions as functional information 
The aim of Chapter 5 was to investigate if protein-protein interactions could be used to 
identify sets of genes between which there is an enrichment of significant statistical 
interactions. 
Efforts have been made in order to create exhaustive protein-protein interactions 
databases. However such databases present some limits. Curating interactions form the 
many small-scale studies to be found in the literature is difficult as it is time consuming: as 
a result many interactions data present in the literature do not appear in databases. The 
quality of data is variable and working out what is of good or bad quality can became an 
enormous task. In addition databases overlap each other and the overlap shows difference 
in annotations due to the difference of interpretation by biologists (Mathivanan et al. 
2006). 
Thorough and comprehensive screens of PPI have emerged such as the Human 
Interactome Project. These resources are very valuable as they contain good quality PPI 
however it is also dependent on the coverage of the search space: the sets of proteins 
between which PPIs have been evaluated. In addition, the literature contains newly 
discovered PPI found in small studies and its number is also increasing. There is an interest 
in developing methods that will allow PPI information to be extracted from scientific 
published articles. 
In Chapter 5, I tested three text-mining tools capable of extracting PPI from abstracts. 
Following a comparison of their performances using standard indicators (precision, recall 
and F-measure) I was able to obtain a set of PPI extracted from PubMed using the best 
tool: Odin. 
I also selected PPI sets from four other sources. The Human Interactome Project data was 
classified into two subsets of PPI: one from comprehensive pairwise screens and the 
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second from PPI extracted from abstracts. A third set was formed by the synaptic set of PPI 
from the Intact database. The last set was comprised of PPI from the String database, which 
contains PPI backed up by Y2H experiments and PPI extracted from the literature. Using 
each set of PPI, I tested whether significant SNP-SNP interactions were enriched within 
such sets of PPI by using a ranking test. Only the set of PPI from the Intact database, 
containing synaptic PPI presented an enrichment of interactions with low p-values. 
However when including more SNPs into the analysis (by using different clumping 
parameters), this effect disappeared. Also the positive result does not necessary imply that 
it is specifically physically-interacting brain genes that are enriched for evidence of 
interactions, as opposed to brain-expressed genes in general. Indeed schizophrenia is a 
brain disorder so significant results could be explained by the selection of brain-related 
genes for the analysis: the genes are more likely to be relevant for the disease so perhaps 
they are also more likely to be enriched with significant interactions (in line with the 
evidence from previous chapters). This hypothesis could be tested by comparing PPI pairs 
form the Intact database with randomly selected pairs of genes known to be involved with 
brain functions. In addition using a bigger dataset is needed in order to fully investigate if 
the effect observed is real. A bigger dataset composed of the ISC and the CLOZUK datasets 
combined could have been used to that extent.  
6.2  Strengths and limitations 
6.2.1  Strengths 
In this thesis I assessed statistical interactions within two independent GWAS datasets. The 
independent analysis in both datasets showed an enrichment of significant interactions 
between genes most highly associated with schizophrenia when comparing to interactions 
between least-associated genes. This provides consistent evidence that interactions could 
contribute to schizophrenia. 
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In addition, the methodology comparison of the three models gave a better insight for 
interactions analysis when dealing with covariates. This work could be useful for future 
analysis using the recommendation made here. 
I also performed a thorough analysis on the use of PPI data in order to identify sets of genes 
between which an enrichment of statistical interactions can be observed. Despite the 
various origin of the PPI set used (from comprehensive screens, databases or PPI extracted 
from the literature) no enrichment was detected except in the synaptic set of PPI. 
Considering many studies have showed a link between schizophrenia and synaptic genes 
(Glessner et al. 2010; Fromer et al. 2014; Kirov, Rujescu, et al. 2009; Kirov et al. 2012) this 
is a potentially interesting finding that needs  to be follow-up in a bigger sample.  
6.2.2  General limitations 
One of the major limitations in an interaction analysis is the lack of power to detect 
statistically significant interactions. Indeed individual interactions contributing to disease 
risk are likely to have modest effect sizes due to the sample size used (Manolio et al. 2009). 
Furthermore the high number of tests performed adds a supplementary challenge with 
regards to Bonferroni multiple testing correction. As the number of interactions tested is 
high, the threshold is highly conservative and result in a loss of power. Perhaps an 
appropriate genome-wide significance threshold should be used for pairwise interactions 
(Musani et al. 2007) such as the one used for the detection of variants in GWAS (p=5e-8). 
On the other side, the power of detection could greatly be improved by using bigger sample 
sizes. 
In this study the chosen SNPs for every interaction analysis were within autosomal genes 
as the main interest was the focus on gene-gene interactions. In addition LD clumping was 
use to restrict the number of SNPs in the analysis: analysing all pair-wise interactions 
without restricting the number of variants is computationally difficult. However it is 
important to be aware that some information may be missed by the use of stringent 
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thresholds. Given the lack of computational power to fully explore the search space of SNP-
SNP interactions, there is a need for a trade-off between computational capacities and 
having sufficient number of markers for the analysis. 
Regarding the different PPI sets used in Chapter 5, there are also some limitations. PPI 
available in database such as String or Intact needs to be better evaluated. In addition, 
while thorough screens contain better quality PPI data, the search space is not completely 
mapped, which can introduce bias in the analysis. For example, the data from the Human 
Interactome Project used here covers only 42% of the search space. With the efforts 
towards the search of the whole proteome, better data will be available and allow us to 
perhaps detect some effects. In addition, the investigation was only performed on the 
CLOZUK dataset and needs to be follow-up on a bigger sample. Imputing the ISC dataset, 
and combining it with the CLOZUK dataset could have resolved that issue but imputing data 
were not available at the time of the analysis.  
6.2.3  Methodology considerations 
In Chapter 3, I compared three different methods to take into account covariates in an 
interaction analysis. The meta-analytic method was used in Chapter 4 and 5 to perform the 
interaction analysis. This method could be improved: only interaction terms were meta-
analysed and perhaps taking into account the direction of the main effect could help to 
improve the accuracy of the method.  
It was argued in Chapter 3 that including covariates in a logistic regression model could 
result in a loss of power of detection when the disease prevalence is low (Pirinen et al. 
2012). As the method used to calculate interactions is based on a logistic regression model, 
perhaps by adjusting for covariates the power of detection is lowered. However if the 
covariates are well known confounds (as it is the case in this thesis), it Is necessary to 
control for their effects and thus to accept the loss of power.  
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In the method used to calculate interactions in this thesis, a logistic function was used as a 
link function to model the relationship between the phenotype and the predictors. This 
choice has important implications: it could be argued that no statistical interaction 
between genes is epistatic (Clayton 2012). However an inappropriate choice of scale could 
result in weakened interaction effects impossible to detect (Frånberg et al. 2015). To 
investigate this, different link functions could be use on the same datasets (Frånberg et al. 
2015; Knol and VanderWeele 2012). 
6.3  Future work 
Regarding the method comparison in Chapter 3, further investigation could be done to 
develop the potential of the meta-analytic approach. For example, the approach used in 
this study meta-analysed the interaction terms only. It would be interesting to see if the 
accuracy of the method can be improved by taking into account the main effects. 
The three methods could also be applied to a different dataset in order to see if the 
correlations between methods replicated. Due to lack of time and computational 
capacities, the three methods weren’t tested on the CLOZUK dataset, which could be used 
for this follow-up analysis. 
In Chapter 4, I presented preliminary results of the analysis of interactions with a low p-
value to assess if biological processes were shared among them. However this analysis 
stays purely descriptive and a thorough investigation needs to be performed in order to 
evaluate if it is possible to identify groups of genes between which an enrichment of 
significant interactions is observed. In addition, DAVID (Sherman et al. 2007) does not take 
into account the gene size or the number of semi-independent SNPs into account. Further 
work could include an enrichment test that accounts for those differences. 
The main issue in current gene-gene interaction studies is the lack of sample size in order 
to detect significant interactions. It would be interesting to use a simulation study under a 
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range of plausible disease models in order to better estimate what sample size would be 
needed to detect interactions in schizophrenia. 
Replication is another major challenge in interaction analysis. It would be interesting to use 
two similar datasets (in term of population and phenotype) and to reproduce the analysis 
presented in Chapter 4. Using similar but larger datasets would allow better control over 
the genetic variability and would perhaps help with the replication of the results. 
The thesis is focused on two-way gene-gene interactions but three-way interactions could 
also be investigated.  
Furthermore and despite obvious computational issues, it would also be of interest to look 
at interactions outside genes: other functional regions of the genome could also play a 
role. Studies have shown that changes in regulatory regions (such as promoters or 
enhancers regions) influence the expression pattern of genes. For short-range interactions, 
extending the gene boundaries would allow to capture interactions between short-range 
enhancers and their genes. However long-range interactions present another challenge 
due to the looping property of the DNA. 
In addition, genes represent only a small portion of the genome and it would be interesting 
to further investigate the non-coding part of the DNA. As expected, computational issues 
would rise as the number of variants to include in such analysis would increase drastically. 
There is a need to prioritize the number of SNPs in the analysis, perhaps using information 
regarding the 3D structure of the DNA. 
The recent development of genome wide chromosome conformation capture (Hi-C) has 
permitted the study of chromatin interactions within the nucleus. The resulting interaction 
maps contain information on loop within the structure of the DNA and possible contacts 
points between enhancers and promoters. This information could perhaps help to narrow 
down the number of variants to test in an interaction analysis. Furthermore, the resulting 
interaction maps show that genomes can be divided into large local chromatin domains 
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termed Topologically Associated Domains (TADs) (Dixon et al. 2012). Within TADs, the 
genome appears to be organized to favour strong internal chromatin interactions rather 
than external interactions with neighbouring TADs. It has also been suggested that TADs 
might help to delineate basic genomic functions such as gene regulation. Further work 
could assess whether significant statistical interactions are enriched within TADs. 
6.4  Conclusion 
To conclude, in the first part of this thesis, I analysed different methods to account for 
population structure in an interaction analysis. 
In the second and third part I investigated two different approaches in order to identify 
sets of genes between which an enrichment of significant interactions can be observed: 
one based on the genetic information and the second one based on functional information 
using protein-protein interactions. Using genetic information, the independent analysis of 
the two GWAS dataset suggested that gene-gene interactions might play a role in 
schizophrenia. In addition there might be some enrichment for interactions amongst genes 
most highly associated with schizophrenia. Further work using GWAS dataset with bigger 
sample size would be needed in order to improve the power to detect interactions. When 
investigating protein-protein interaction datasets the only evidence for enrichment of 
significant interactions was observed in the synaptic dataset. This potentially interesting 
finding needs to be further investigated.  
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